US20100312333A1 - Apparatus and method for replacing a diseased cardiac valve - Google Patents

Apparatus and method for replacing a diseased cardiac valve Download PDF

Info

Publication number
US20100312333A1
US20100312333A1 US12/769,593 US76959310A US2010312333A1 US 20100312333 A1 US20100312333 A1 US 20100312333A1 US 76959310 A US76959310 A US 76959310A US 2010312333 A1 US2010312333 A1 US 2010312333A1
Authority
US
United States
Prior art keywords
cardiac valve
native cardiac
expandable support
support member
expandable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/769,593
Inventor
Jose Luis Navia
Ji-Feng Chen
Qun Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cleveland Clinic Foundation
Original Assignee
Cleveland Clinic Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cleveland Clinic Foundation filed Critical Cleveland Clinic Foundation
Priority to US12/769,593 priority Critical patent/US20100312333A1/en
Priority to US12/828,991 priority patent/US8685086B2/en
Priority to PCT/US2010/040786 priority patent/WO2011002996A2/en
Priority to CA2767035A priority patent/CA2767035C/en
Priority to EP10794766.5A priority patent/EP2448522A4/en
Priority to AU2010266210A priority patent/AU2010266210B2/en
Assigned to THE CLEVELAND CLINIC FOUNDATION reassignment THE CLEVELAND CLINIC FOUNDATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NAVIA, JOSE L., CHEN, JI-FENG, ZHOU, QUN
Publication of US20100312333A1 publication Critical patent/US20100312333A1/en
Priority to US14/230,216 priority patent/US10010416B2/en
Priority to AU2014280916A priority patent/AU2014280916B2/en
Priority to US16/025,977 priority patent/US10939999B2/en
Priority to US17/067,580 priority patent/US20210161657A1/en
Priority to US17/556,830 priority patent/US20220110748A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427Devices for manipulating or deploying heart valves during implantation
    • A61F2/2436Deployment by retracting a sheath
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/005Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0066Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements stapled
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0075Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0069Three-dimensional shapes cylindrical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0073Quadric-shaped
    • A61F2230/0078Quadric-shaped hyperboloidal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/006Additional features; Implant or prostheses properties not otherwise provided for modular
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0096Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
    • A61F2250/0098Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00023Titanium or titanium-based alloys, e.g. Ti-Ni alloys

Definitions

  • the present invention relates generally to apparatus and methods for treating heart disease, and more particularly to self-expandable apparatus and methods for treating diseased cardiac valves.
  • AV valves There are two atrioventricular (AV) valves in the heart; one on the left side of the heart and one on the right side of the heart.
  • the left side AV valve is the mitral valve and the right side AV valve is the tricuspid valve. Both of these valves are subject damage and dysfunction that requires that the valve be repaired or replaced.
  • the mitral and tricuspid valves differ significantly in anatomy. While the annulus of the mitral valve is generally D-shaped, the annulus of the tricuspid valve is more circular. The effects of valvular dysfunction vary between the mitral valve and the tricuspid valve. Mitral valve regurgitation has more severe physiological consequences to the patient than does tricuspid valve regurgitation, a small amount of which is tolerable.
  • mitral valve insufficiency the valve leaflets do not fully close and a certain amount of blood leaks back into the left atrium when the left ventricle contracts.
  • the heart has to work harder by pumping not only the regular volume of blood, but also the extra volume of blood that regurgitated back into the left atrium.
  • the added workload creates an undue strain on the left ventricle. This strain can eventually wear out the heart and result in morbidity. Consequently, proper function of the mitral valve is critical to the pumping efficiency of the heart.
  • Mitral and tricuspid valve disease is traditionally treated by either surgical repair with an annuloplasty ring or surgical replacement with a valve prosthesis.
  • Surgical valve replacement or repair is often an exacting operation. The operation requires the use of a heart-lung machine for external circulation of the blood as the heart is stopped and then opened during the surgical intervention. Once the heart is opened, the artificial cardiac valves and/or annuloplasty rings are sewed in under direct vision.
  • Surgical repair of the AV valves exposes patients (i.e., elderly patients) to many risks.
  • a minimally invasive procedure that could be performed under local anesthesia in the cardiac catheterization lab, rather than in cardiac surgery, could therefore offer tremendous benefits to these patients. Consequently, an apparatus for replacing a diseased AV valve using a minimally invasive approach would be very helpful in providing additional opportunities to treat patients with valvular insufficiency and/or end stage heart failure.
  • an apparatus for replacing a native cardiac valve.
  • the native cardiac valve has at least one leaflet and is surrounded by a native cardiac valve annulus.
  • the native cardiac valve annulus has a superior aspect and an inferior aspect.
  • the apparatus comprises a barbell-shaped, expandable anchoring member including a first end portion, a second end portion, and a main body portion extending between the end portions.
  • the main body portion includes a channel defined by an inner surface and an outer surface.
  • Each of the first and second end portions has a diameter greater than the diameter of the main body portion.
  • the first and second end portions are sized to respectively contact the superior and inferior aspects of the native cardiac valve annulus when the expandable anchoring member is in an expanded configuration.
  • the apparatus also includes an expandable support member operably disposed within the main body portion of the expandable anchoring member, and a prosthetic cardiac valve secured within the expandable support member.
  • a method for replacing a native cardiac valve.
  • the native cardiac valve has at least one leaflet and is surrounded by a native cardiac valve annulus.
  • the native cardiac valve annulus has a superior aspect and an inferior aspect.
  • One step of the method comprises providing an apparatus including a barbell-shaped expandable anchoring member, an expandable support member, and a prosthetic cardiac valve secured within the expandable support member.
  • the expandable support member is secured within the expandable anchoring member.
  • Each of the first and second end portions has a diameter greater than the diameter of the main body portion.
  • the apparatus is placed into a delivery catheter, and the delivery catheter inserted into an atrial chamber. The delivery catheter is advanced until the delivery catheter is positioned within the native cardiac valve annulus.
  • the apparatus is removed from the delivery catheter so that the expandable anchoring member obtains an expanded configuration and the first and second end portions of the expandable anchoring member respectively contact the superior and inferior aspects of the native cardiac valve annulus and thereby secure the expandable anchoring member in the native cardiac annulus.
  • an apparatus for replacing a native cardiac valve.
  • the native cardiac valve has at least one leaflet and is surrounded by a native cardiac valve annulus.
  • the native cardiac valve annulus has a superior aspect and an inferior aspect.
  • the apparatus comprises an expandable support member, a prosthetic cardiac valve operably secured within the expandable support member, and a securing member operably connected to the expandable support member.
  • the securing member comprises an elongated body member having a first end, a second end, and a main body portion extending between the first and second ends.
  • the second end includes a first attachment member operably connected thereto for contacting the inferior aspect of the native cardiac valve annulus when the expandable support member is in an expanded configuration.
  • a method for replacing a native cardiac valve.
  • the native cardiac valve has at least one leaflet and is surrounded by a native cardiac valve annulus.
  • the native cardiac valve annulus has a superior aspect and an inferior aspect.
  • One step of the method comprises providing an apparatus including an expandable support member having a prosthetic cardiac valve secured therein and a securing member operably connected to the expandable support member.
  • the securing member comprises an elongated body member having a first end, a second end, and a main body portion extending between the first and second ends.
  • the second end includes a first attachment member operably connected thereto.
  • the expandable anchoring member is placed into a delivery catheter, and the delivery catheter is then inserted into an atrial chamber.
  • the delivery catheter is advanced until the delivery catheter is positioned within the native cardiac valve annulus.
  • the apparatus is removed from the delivery catheter so that the expandable support member obtains an expanded configuration and the first attachment member of the securing member contacts the inferior aspect of the native cardiac valve annulus and thereby secures the expandable support member in the native cardiac valve annulus.
  • an apparatus for replacing a native cardiac valve.
  • the native cardiac valve has at least one leaflet and is surrounded by a native cardiac valve annulus.
  • the native cardiac valve annulus has a superior aspect and an inferior aspect.
  • the apparatus comprises a securing member including an elongated body member having a first end, a second end, and a main body portion extending between the first and second ends.
  • the second end includes a first attachment member operably connected thereto for contacting the inferior aspect of the native cardiac valve annulus when the expandable support member is in an expanded configuration.
  • the apparatus also comprises a prosthetic valve operably secured to the securing member.
  • a method for replacing a native cardiac valve.
  • the native cardiac valve has at least one leaflet and is surrounded by a native cardiac valve annulus.
  • the native cardiac valve annulus has a superior aspect and an inferior aspect.
  • One step of the method includes providing an apparatus comprising a securing member and a prosthetic cardiac valve operably connected to the securing member.
  • the securing member comprises an elongated body member having a first end, a second end, and a main body portion extending between the first and second ends.
  • the second end includes a first attachment member operably connected thereto for contacting the inferior aspect of the native cardiac valve annulus when the expandable support member is in an expanded configuration.
  • the apparatus is placed into a delivery catheter, and the delivery catheter is then inserted into an atrial chamber.
  • the delivery catheter is advanced until the delivery catheter is positioned within the native cardiac valve annulus.
  • the apparatus is removed from the delivery catheter so that the prosthetic cardiac valve expands in place of the native cardiac valve and the first attachment member of the securing member contacts the inferior aspect of the native cardiac valve annulus and thereby secures the prosthetic cardiac valve in the native cardiac valve annulus.
  • FIG. 1A is a perspective view of an expandable anchoring member constructed in accordance with the present invention.
  • FIG. 1B is a perspective view of a prosthetic valve operably secured to an expandable support member
  • FIG. 10 is a perspective view of an apparatus for replacing a native cardiac valve constructed in accordance with the present invention.
  • FIG. 1D is a cross-sectional view of the apparatus shown in FIG. 10 ;
  • FIG. 1E is a top plan view of the apparatus shown in FIG. 10 ;
  • FIG. 2 is a cross-sectional view of a human heart
  • FIG. 3A is a perspective view showing an alternative embodiment of the expandable anchoring member in FIG. 1A ;
  • FIG. 3B is a perspective view showing an alternative embodiment of the apparatus in FIG. 10 ;
  • FIG. 4 is a perspective view showing the apparatus of FIG. 10 being delivered to a native mitral valve
  • FIG. 5 is a cross-sectional view showing the apparatus of FIG. 10 implanted in a native mitral valve
  • FIG. 6A is a cross-sectional view showing another alternative embodiment of the apparatus in FIG. 10 ;
  • FIG. 6B is a cross-sectional view showing an alternative embodiment of the apparatus in FIG. 6A ;
  • FIG. 6C is a cross-sectional view showing another alternative embodiment of the apparatus in FIG. 6A ;
  • FIG. 6D is a cross-sectional view showing another alternative embodiment of the apparatus in FIG. 6A ;
  • FIG. 6E is a cross-sectional view showing another alternative embodiment of the apparatus in FIG. 6A ;
  • FIG. 7 is a perspective view showing the apparatus of FIG. 6A being delivered to a native mitral valve
  • FIG. 8 is a cross-sectional view showing the apparatus of FIG. 6A implanted in a native mitral valve
  • FIG. 9 is a cross-sectional view showing another alternative embodiment of the apparatus in FIG. 6A ;
  • FIG. 10 is a cross-sectional view showing the apparatus of FIG. 9 implanted in a native mitral valve
  • FIG. 11 is a cross-sectional view showing another alternative embodiment of the apparatus in FIG. 6A ;
  • FIG. 12 is a cross-sectional view showing the apparatus of FIG. 11 implanted in a native mitral valve.
  • the present invention relates generally to apparatus and methods for treating heart disease, and more particularly to self-expandable apparatus and methods for treating diseased cardiac valves.
  • FIGS. 1A-E illustrate one embodiment of an apparatus 10 for replacing a native cardiac valve.
  • the present invention is described herein as being useful for treating a diseased mitral valve, it should be appreciated that other cardiac valves, such as the tricuspid valve, the pulmonary valve, and the aortic valve are also treatable according to the present invention.
  • FIG. 2 shows a human heart 12 .
  • the human heart 12 contains four chambers: the right and left atria 14 and 16 and the right and left ventricles 18 and 20 .
  • the thin-walled right atrium 14 receives deoxygenated blood from the superior vena cava 22 , the inferior vena cava (not shown), and from the coronary sinus (not shown).
  • the thin-walled left atrium 16 receives oxygenated blood from pulmonary veins 24 .
  • the right and left ventricles 18 and 20 pump oxygenated and deoxygenated blood, respectively, throughout the body, and the pocket-like pulmonary (not shown) and aortic 26 semilunar valves prevent reflux into the ventricles.
  • Atrial blood is pumped through the atrioventricular orifices, guarded by the 3-cusp tricuspid valve 28 on the right and the 2-cusp mitral valve 30 on the left.
  • the mitral valve 30 is formed by two leaflets; namely, the anterior leaflet 32 and the posterior leaflet 34 .
  • the anterior leaflet 32 extends along a generally planar base of a D-shaped mitral annulus 36 ( FIG. 5 ), while the posterior leaflet 34 ( FIG. 2 ) extends arcuately around the curved portion of the annulus.
  • the mitral and tricuspid valves 28 and 30 are secured to the papillary muscles 38 in the right and left ventricles 18 and 20 by tendinous chordae tendineae 40 , and by the mitral annulus 36 and the tricuspid annulus (not shown in detail).
  • one embodiment of the present invention includes an apparatus 10 for replacing a native cardiac valve, such as a native mitral valve 30 .
  • the apparatus 10 comprises a barbell-shaped expandable anchoring member 42 .
  • the expandable anchoring member 42 includes a first end portion 44 , a second end portion 46 , and a main body portion 48 extending between the first and second end portions.
  • the main body portion 48 includes a channel 50 defined by an inner surface 52 and an outer surface 54 .
  • the main body portion 48 has a generally cylindrical shape and is adapted to conform to the three-dimensional shape of a native cardiac valve annulus. It will be appreciated that the size and shape of the main body portion 48 may be varied as needed. For example, the diameter, circumference, and/or length of the main body portion 48 may be varied so that the expandable anchoring member 42 more readily conforms to the shape of a native cardiac valve annulus.
  • Each of the first and second end portions 44 and 46 of the expandable anchoring member 42 has a diameter that is greater than the diameter of the main body portion 48 .
  • the first and second end portions 44 and 46 are sized to respectively contact the superior and inferior aspects of a native cardiac valve annulus when the expandable anchoring member 42 is in an expanded configuration.
  • the first and second end portions 44 and 46 can have identical or different configurations. As shown in FIG. 1A , for example, the first and second end portions 44 and 46 have a hemi-spherical shape with respect to an axial plane AP of the main body portion 48 .
  • the first and second end portions 44 and 46 of the expandable anchoring member 42 can have bulbous shape ( FIGS. 3A-B ).
  • the expandable anchoring member 42 is comprised of a single strand of a flexibly resilient material, such as Nitinol, stainless steel, or other suitable medical grade metals or plastics having shape memory characteristics. It will be appreciated, however, that the expandable anchoring member 42 can alternatively be comprised of multiple strands. Additionally, at least a portion of the expandable anchoring member 42 may be made from a bioabsorbable material including, for example, magnesium alloy, dendrimers, biopolymers such as thermoplastic starch, polyalctides, cellulose, and aliphatic aromatic copolyesters. The expandable anchoring member 42 may also be made of a radio-opaque material or include radio-opaque markers (not shown) to facilitate fluoroscopic visualization. The flexible and expandable properties of the expandable anchoring member 42 facilitate delivery of the apparatus 10 to a diseased native cardiac valve.
  • a flexibly resilient material such as Nitinol, stainless steel, or other suitable medical grade metals or plastics having shape memory characteristics
  • the apparatus 10 additionally includes an expandable support member 56 ( FIG. 1B ) operably disposed within the main body portion 48 of the expandable anchoring member 42 .
  • the expandable support member 56 can be secured within the main body portion 48 using any one or combination of known fastening means (not shown), such as sutures, clips, pins, staples, adhesives, or the like.
  • the expandable support member 56 includes oppositely disposed proximal and distal end portions 58 and 60 , and a main body portion 62 extending between the end portions.
  • the expandable support member 56 is both flexible and resilient and, as discussed in more detail below, can be made of a shape memory material such as Nitinol, stainless steel, or other suitable medical grade metals or plastics having shape memory characteristics.
  • the expandable support member 56 may additionally or optionally be made from a bioabsorbable material including, for example, magnesium alloy, dendrimers, biopolymers such as thermoplastic starch, polyalctides, cellulose, and aliphatic aromatic copolyesters.
  • the expandable support member 56 may also be made of a radio-opaque material or include radio-opaque markers to facilitate fluoroscopic visualization.
  • the flexible and expandable properties of the expandable support member 56 facilitate placement and movement of the expandable support member within the main body portion 48 of the expandable anchoring member 42 .
  • the expandable support member 56 comprises a continuous series of W-shaped segments which collectively form a mesh-like configuration. It is contemplated, however, that other geometries may be used.
  • the lower tips 64 as viewed in FIG. 1B , of the W-shaped segments form the distal end portion 60 of the expandable support member 56
  • the upper tips 66 of the W-shaped segments form the proximal end portion 58 of the expandable support member.
  • Other examples of expandable support members 56 which may be used as part of the present invention are disclosed in U.S. Patent Pub. No. 2007/0255389 A1, the entirety of which is hereby incorporated by reference.
  • the expandable support member 56 also includes a prosthetic valve 68 operably secured therein.
  • the prosthetic valve 68 is secured to the expandable support member 56 using any one or combination of known fastening means (not shown), such as sutures, pins, clips, staples, adhesives, or the like.
  • Examples of prosthetic valves 68 are known in the art and can include, for instance, the prosthetic valves disclosed in U.S. Pat. No. 5,156,621, which is hereby incorporated by reference in its entirety.
  • the prosthetic valve 68 may be fixed and preserved using a variety of known methods.
  • the use of chemical processes for the fixation and preservation of biological tissues have been described and are readily available in the art.
  • glutaraldehyde and other related aldehydes have seen widespread use in preparing cross-linked biological tissues.
  • Glutaraldehyde is a five carbon aliphatic molecule with an aldehyde at each end of the chain, rendering it bifunctional. These aldehyde groups react under physiological conditions with primary amine groups on collagen molecules resulting in the cross-linking of collagen containing tissues.
  • Methods for glutaraldehyde fixation of biological tissues have been extensively described and are well known in the art. In general, a biological tissue sample to be cross-linked is simply contacted with a glutaraldeyde solution for a duration effective to cause the desired degree of cross-linking within the biological tissue being treated.
  • the prosthetic valve 68 may also be treated and preserved with a dry tissue valve procedure as described in U.S. Pat. No. 6,534,004, the entire contents of which are hereby incorporated by reference. Furthermore, the prosthetic valve 68 may be treated with anti-calcification solutions, such as XenoLogiX® treatment (Edwards Lifesciences, Irvine, Calif.), the SynerGraf® (CryoLife, Inc., Kennesaw, Ga.) treatment process, and/or anti-calcification agents, such as a-amino oleic acid.
  • anti-calcification solutions such as XenoLogiX® treatment (Edwards Lifesciences, Irvine, Calif.), the SynerGraf® (CryoLife, Inc., Kennesaw, Ga.) treatment process, and/or anti-calcification agents, such as a-amino oleic acid.
  • the apparatus 10 may further include a layer (not shown) of biocompatible material covering at least a portion of the expandable anchoring member.
  • the layer of biocompatible material may be synthetic, such as Dacron® (Invista, Wichita, Kans.), woven velour, polyurethane, polytetrafluoroethylene (PTFE), expanded PTFE, Gore-Tex® (W. L. Gore & Associates, Flagstaff, Ariz.), or heparin-coated fabric.
  • the layer may be a biological material, such as bovine or equine pericardium, peritoneal tissue, an allograft, a homograft, a patient graft, or a cell-seeded tissue.
  • the layer can cover either the inner surface 52 of the expandable anchoring member 42 , the outer surface 54 of the expandable anchoring member, or a combination thereof.
  • the layer may be attached around the entire circumference of the expandable anchoring member 42 or, alternatively, may be attached in pieces or interrupted sections to allow the expandable anchoring member to more easily expand and contract. By covering a portion of the expandable anchoring member 42 with a layer of biocompatible material, the hemocompatibility of the apparatus 10 may be improved.
  • At least a portion of the apparatus 10 may be treated with a therapeutic agent for eluting into cardiac tissue and/or blood.
  • the therapeutic agent may be capable of treating a variety of pathological conditions including, but not limited to, thrombosis, stenosis and inflammation.
  • the therapeutic agent may include at least one of an anticoagulant, an antioxidant, a fibrinolytic, a steroid, an anti-apoptotic agent, an anti-inflammatory agent, a receptor agonist or antagonist, and/or a hormone.
  • the therapeutic agent may be capable of treating or preventing other diseases or disease processes, such as microbial infections.
  • the therapeutic agent may include an anti-microbial agent and/or a biological agent such as a cell, peptide or nucleic acid.
  • the therapeutic agent can be simply linked to a surface of the apparatus 10 , embedded and released from within polymer materials, such as a polymer matrix, or surrounded by and released through a carrier. The entire apparatus 10 , or only a portion thereof, may be treated with the therapeutic agent. Additionally, different portions of the apparatus 10 may be treated with different therapeutic agents.
  • the apparatus 10 shown in FIGS. 1A-E and FIGS. 3A-B can be used to replace a diseased mitral valve 30 , for example, using any one or combination of known surgical methods.
  • an apical puncture method can be used to respectively deliver the apparatus 10 shown in FIG. 10 .
  • the apparatus 10 can be delivered to the tricuspid valve 28 via the pulmonary artery (not shown) or to the mitral valve 30 via the aortic valve 26 .
  • the method of the present invention will typically entail gaining access to a beating heart 12 ; however, the present invention may also be used for intravascular stopped-heart access as well as stopped-heart open chest procedures.
  • FIG. 4 illustrates one step of an apical puncture method for delivering the apparatus 10 shown in FIG. 1C to a native cardiac valve, such as the mitral valve 30 .
  • One step of the method includes placing the apparatus 10 into a delivery catheter 70 .
  • the delivery catheter 70 has proximal end portion 72 and a distal end portion 74 .
  • the delivery catheter 70 is shaped to facilitate insertion and removal of the apparatus 10 into and out of a puncture tool 76 (not shown in detail).
  • the delivery catheter 70 may be constructed from a rigid, semi-rigid, or flexible material.
  • the delivery catheter 70 may be made of a flexible elastic material, such as a shape memory alloy, a super-elastic material (e.g., Nitinol, spring stainless steel, etc.), or plastic.
  • the delivery catheter 70 may be made of a rigid material, such as hardened plastic, silicon, polyurethane, or the like.
  • the dimensions of the native mitral valve 30 and the native mitral annulus 36 Prior to placing the apparatus 10 into the delivery catheter 70 , the dimensions of the native mitral valve 30 and the native mitral annulus 36 are determined.
  • Various methods and devices for determining the dimensions of cardiac valves and cardiac valve annuluses are known in the art and include, for example, echocardiogram, computed tomography, magnetic resonance imaging, fluoroscopy, and angiography.
  • an appropriately-sized apparatus 10 is chosen for implantation.
  • the main body portion 48 of the expandable anchoring member 42 can be appropriately-sized so that the diameter of the main body portion corresponds to the diameter of the native mitral annulus 36 .
  • first and second end portions 44 and 46 of the expandable anchoring member 42 can also be appropriately-sized so that the first and second end portions respectively contact the superior and inferior aspects 78 and 80 of the mitral annulus 36 when the expandable anchoring member is in an expanded configuration.
  • the puncture tool 76 is used to puncture the chest wall and extend through the apical portion of the left ventricle 20 into the left ventricular chamber.
  • the delivery catheter 70 is then urged through the puncture tool 76 as shown in FIG. 4 so that the delivery catheter is positioned at a distal end portion 82 of the puncture tool.
  • Both the puncture tool 76 and the delivery catheter 70 are then progressively withdrawn so that the first end portion 44 of the expandable anchoring member 42 expands to contact the superior aspect 78 of the native mitral annulus 36 .
  • the main body portion 48 and the second end portion 46 of the expandable anchoring member 42 expand into the native mitral annulus 36 ( FIG. 5 ). With the apparatus 10 securely positioned in the native mitral annulus 36 , normal blood flow can resume through the prosthetic valve 68 .
  • FIGS. 6A-E Another embodiment of the present invention is illustrated in FIGS. 6A-E .
  • the apparatus 10 a is identically constructed as the apparatus 10 shown in FIGS. 1A-E , except where as described below.
  • FIGS. 6A-E structures that are identical as structures in FIGS. 1A-E use the same reference numbers, whereas structures that are similar but not identical carry the suffix “a”.
  • An apparatus 10 a for replacing a native cardiac valve, such as a native mitral valve 30 can comprise an expandable support member 56 and a prosthetic cardiac 68 valve operably secured within the expandable support member. As shown in FIGS. 6A-E , the apparatus 10 a can further include a securing member 84 operably connected to the expandable support member 56 .
  • the securing member 84 can comprise an elongated body member 86 having a first end 88 , a second end 90 , and a main body portion 92 extending between the first and second ends.
  • the securing member 84 can be operably secured to the expandable support member 56 using any one or combination of known fastening means (not shown), such as sutures, clips, pins, staples, adhesives, or the like.
  • the second end 90 of the elongated body member 84 can include a first attachment member 94 operably connected thereto for contacting the inferior aspect of the native cardiac valve annulus when the expandable support member 56 is in an expanded configuration.
  • the first end 88 of the elongated body member 86 can also include a second attachment member 96 operably connected thereto for contacting the superior aspect of the native cardiac valve annulus when the expandable support member 56 is in an expanded configuration.
  • the first and second attachment members 94 and 96 can be made from any one or combination of flexibly resilient, medical grade materials, including, for example, Nitinol, stainless steel, or other suitable metals or plastics having shape memory characteristics.
  • the first and second attachment members 94 and 96 can have a variety of configurations. As shown in FIGS. 6A-C , for example, the first and second attachment members 94 and 96 can include flexible, rod-shaped members 98 .
  • the rod-shaped members 98 can be joined to or integrally formed with the elongated body member 86 so that the rod-shaped members can transition from a collapsed configuration (indicated by the dashed lines) to an expanded configuration. In the collapsed configuration, the rod-shaped members 98 can extend substantially parallel to the elongated body member 86 . In the expanded configuration, the rod-shaped members 98 can extend substantially axial to the elongated body member 86 .
  • the rod-shaped members 98 located at the first and second ends 88 and 90 of the elongated body member 86 can respectively contact the superior and inferior aspects 78 and 80 of the mitral annulus 36 when the apparatus 10 a is in an expanded configuration.
  • the first and second attachment members 94 and 96 can also comprise a windable coil 100 .
  • the windable coil 100 can be made of a flexible wire or rod capable of transitioning between an expanded configuration and a collapsed configuration. In the expanded configuration (indicated by the dashed lines), the windable coil 100 can obtain a substantially linear configuration so that the windable coil extends substantially parallel to the elongated body member 86 . In the collapsed configuration ( FIGS. 6B-D ), the windable coil 100 can obtain a substantially circular configuration and extend substantially axial to the elongated body member 86 .
  • each of the windable coils 100 located at the first and second ends 88 and 90 of the elongated body member 86 can respectively contact the superior and inferior aspects 78 and 80 of a native mitral annulus 36 when the apparatus 10 a is in an expanded configuration.
  • the first and second attachment members 94 and 96 can additionally comprise an anchoring ring 102 ( FIG. 6E ).
  • the anchoring ring 102 can be similarly or identically constructed as the first and second end portions 44 and 46 of the expandable anchoring member 42 shown in FIGS. 3A-B .
  • the anchoring ring 102 can have a bulbous shape and extend substantially axial to the elongated body member 86 .
  • the anchoring ring 102 In a collapsed configuration (indicated by dashed lines), the anchoring ring 102 can extend substantially parallel to the elongated body member 86 .
  • the anchoring ring 102 can be made of a flexible, mesh-like material having shape memory characteristics.
  • the apparatus 10 a shown in FIGS. 6A-E can additionally include a layer 104 ( FIG. 8 ) of material that extends around all or a portion of the expandable support member 56 .
  • the layer 104 of material can be made of any one or combination of known biocompatible materials, some of which are described above.
  • the layer 104 can be made of PTFE or ePTFE.
  • the layer 104 of material can function as a seal to prevent leakage of blood between the left atrium 16 and the left ventricle 20 , for example, when the apparatus 10 a is implanted in a heart 12 .
  • the apparatus 10 a shown in FIGS. 6A-E can be used to replace a native mitral valve 30 , for example, using any one or combination of known surgical methods.
  • an apical puncture method can be used to deliver the apparatus 10 a shown in FIG. 6A to a native mitral valve 30 .
  • other percutaneous, transvascular, and/or open surgical methods may be used to deliver the apparatus 10 a to a native mitral valve 30 .
  • the method of the present invention will typically entail gaining access to a beating heart 12 ; however, the present invention may also be used for intravascular stopped-heart access as well as stopped-heart open chest procedures.
  • the apparatus 10 a shown in FIG. 6A can be delivered to a native mitral valve 30 using an apical puncture method similar or identical to the apical puncture method described above.
  • one step of the method can include placing the apparatus 10 a into a delivery catheter 70 .
  • the dimensions of the native mitral valve 30 and the native mitral annulus 36 can be determined.
  • a puncture tool 76 can be used to puncture the chest wall.
  • the puncture tool 76 can then be extended through the apical portion of the left ventricle 20 into the left ventricular chamber.
  • the delivery catheter 70 can be urged through the puncture tool 76 as shown in FIG. 7 so that the delivery catheter is positioned at a distal end portion 82 of the puncture tool.
  • Both the puncture tool 76 and the delivery catheter 70 can then be progressively withdrawn from the left ventricle 20 so that the expandable support member 56 can expand into contact with the native mitral annulus 36 , and the rod-shaped members 98 can transition from the collapsed configuration to the expanded configuration.
  • the rod-shaped members 98 located at the first and second ends 88 and 90 of the elongated body members 86 can respectively contact the superior and inferior aspects 78 and 80 of the mitral annulus 36 and thereby secure the apparatus 10 a in the native mitral annulus ( FIG. 8 ). With the apparatus 10 a securely positioned in the native mitral annulus 36 , normal blood flow can resume through the prosthetic valve 68 .
  • FIG. 9 Another embodiment of the present invention is illustrated in FIG. 9 .
  • the apparatus 10 b is identically constructed as the apparatus 10 a shown in FIGS. 6A-E , except where as described below.
  • FIG. 9 structures that are identical as structures in FIGS. 6A-E use the same reference numbers, whereas structures that are similar but not identical carry the suffix “b”.
  • An apparatus 10 b for replacing a native cardiac valve, such as a mitral valve 30 can comprise an expandable support member 56 and a prosthetic valve 68 operably secured within the expandable support member. As shown in FIG. 9 , the apparatus 10 b can further include a securing member 84 operably connected to the expandable support member 56 .
  • the securing member 84 can comprise an elongated body member 86 having a first end 88 , a second end 90 , and a main body portion 92 extending between the first and second ends.
  • the securing member 84 can be operably secured to the expandable support member 56 using any one or combination of known fastening means (not shown), such as sutures, clips, pins, staples, adhesives, or the like.
  • the second end 90 of the elongated body member 86 can also include a first attachment member 94 operably connected thereto for embedding into the annular tissue at the inferior aspect of a native cardiac valve annulus.
  • the first attachment member 94 can include at least one rod-shaped puncturing member 106 .
  • the puncturing member 106 can have a fixed length or, alternatively, the puncturing member can have a compressible, spring-like configuration (not shown).
  • the puncturing member 106 can have a needle- or barb-like shape to facilitate penetration of the puncturing member into annular tissue.
  • the apparatus 10 b is capable of transitioning between a collapsed configuration and an expanded configuration.
  • the puncturing member 106 can extend substantially axial to the elongated body member 86 in the expanded configuration.
  • the puncturing member 106 can extend substantially parallel to the elongated body member 86 .
  • the puncturing member 106 can be used to secure the apparatus 10 b in a native cardiac valve annulus.
  • the apparatus 10 b shown in FIG. 9 can be delivered to a native cardiac valve, such as a mitral valve 30 using an apical puncture method similar or identical to the apical puncture method described above.
  • one step of the method can include placing the apparatus 10 b into a delivery catheter 70 .
  • the dimensions of the native mitral valve 30 and the native mitral annulus 36 can be determined.
  • the puncture tool 76 can be used to puncture the chest wall.
  • the puncture tool 76 can then be extended through the apical portion of the left ventricle 20 into the left ventricular chamber.
  • the delivery catheter 70 can be urged through the puncture tool 76 so that the delivery catheter is positioned at a distal end portion 82 of the puncture tool (not shown).
  • Both the puncture tool 76 and the delivery catheter 70 can then be progressively withdrawn from the left ventricle 20 so that the expandable support member 56 expands into contact with the native mitral annulus 36 .
  • each of the puncture members 106 can transition from the collapsed configuration to the expanded configuration.
  • each of the puncture members 106 can penetrate into the annular tissue at the inferior aspect 80 of the native mitral annulus 36 and thereby secure the apparatus 10 b in the native mitral annulus ( FIG. 10 ). With the apparatus 10 b securely positioned in the native mitral annulus 36 , normal blood flow can resume through the prosthetic valve 68 .
  • FIG. 11 Another embodiment of the present invention is illustrated in FIG. 11 .
  • the apparatus 10 c is identically constructed as the apparatus 10 a shown in FIGS. 6A-E , except where as described below.
  • structures that are identical as structures in FIGS. 6A-E use the same reference numbers, whereas structures that are similar but not identical carry the suffix “c”.
  • An apparatus 10 c for replacing a native cardiac valve, such as a mitral valve 30 can comprise a prosthetic valve 68 operably secured to a securing member 84 .
  • the securing member 84 can comprise an elongated body member 86 having a first end 88 , a second end 90 , and a main body portion 92 extending between the first and second ends.
  • the securing member 84 can be operably secured to the prosthetic valve 68 using any one or combination of known fastening means (not shown), such as sutures, clips, pins, staples, adhesives, or the like.
  • the second end 90 of the elongated body member 86 can include a first attachment member 94 operably connected thereto for contacting the inferior aspect of a native cardiac valve annulus when the apparatus 10 c is in an expanded configuration.
  • the first end 88 of the elongated body member 86 can also include a second attachment member 96 operably connected thereto for contacting the superior aspect of a native cardiac valve annulus when the apparatus 10 c is in an expanded configuration.
  • the first and second attachment members 94 and 96 can be made from any one or combination of flexibly resilient, medical grade materials, including, for example, Nitinol, stainless steel, or other suitable metals or plastics having shape memory characteristics.
  • the first and second attachment members 94 and 96 can have a variety of configurations. As shown in FIG. 11 , for example, the first and second attachment members 94 and 96 can include flexible, rod-shaped members 98 . It will be appreciated, however, that the first and second attachment members 94 and 96 can also comprise any one or combination of the structures illustrated in FIGS. 6A-E .
  • the rod-shaped members 98 can be joined to or integrally formed with the elongated body member 86 so that the rod-shaped members can transition from a collapsed configuration (indicated by dashed lines) to an expanded configuration. In the collapsed configuration, the rod-shaped members 98 can extend substantially parallel to the elongated body member 86 .
  • the rod-shaped members 98 can extend substantially axial to the elongated body member 86 .
  • the rod-shaped members 98 located at the first and second ends 88 and 90 of the elongated body member 86 can respectively contact the superior and inferior aspects 78 and 80 of the mitral annulus 36 when the apparatus 10 c is in an expanded configuration.
  • the apparatus 10 c shown in FIG. 11 can be used to replace a native cardiac valve, such as a native mitral valve 30 using an apical puncture method similar or identical to the apical puncture method described above.
  • one step of the method can include placing the apparatus 10 c into a delivery catheter 70 .
  • the dimensions of the native mitral valve 30 and the native mitral annulus 36 can be determined.
  • a puncture tool 76 can be used to puncture the chest wall.
  • the puncture tool 76 can then be extended through the apical portion of the left ventricle 20 into the left ventricular chamber. Next, the delivery catheter 70 can be urged through the puncture tool 76 so that the delivery catheter is positioned at a distal end portion 82 of the puncture tool (not shown).
  • Both the puncture tool 76 and the delivery catheter 70 can then be progressively withdrawn from the left ventricle 20 so that prosthetic valve 68 expands into contact with the native mitral annulus 36 , and the rod-shaped members 98 located at the first end 88 of each of the elongated body members 86 transitions from the collapsed configuration to the expanded configuration.
  • the rod-shaped members 98 located at the first and second ends 88 and 90 of each of the elongated body members 86 can respectively contact the superior and inferior aspects 78 and 80 of the mitral annulus 36 , thereby securing the apparatus 10 c in the native mitral annulus ( FIG. 12 ). With the apparatus 10 c securely positioned in the native mitral annulus 36 , normal blood flow can resume through the prosthetic valve 68 .
  • the methods of the present invention can include implanting an expandable anchoring member 42 or an expandable support member 56 , without a prosthetic valve 68 attached therein, in a native cardiac valve annulus. After the expandable anchoring member 42 or the expandable support member 56 is securely positioned in the native cardiac valve annulus, a prosthetic valve 68 can then be secured therein using any one or combination of known fastening means.
  • a prosthetic valve 68 can then be secured therein using any one or combination of known fastening means.

Abstract

An apparatus is provided for replacing a native cardiac valve. The native cardiac valve has at least one leaflet and is surrounded by a native cardiac valve annulus having superior and inferior aspects. The apparatus comprises a barbell-shaped, expandable anchoring member including first, second, and main body portions extending between the end portions. The main body portion includes a channel defined by inner and outer surfaces. Each of the first and second end portions has a diameter greater than the diameter of the main body portion. The first and second end portions are sized to respectively contact the superior and inferior aspects of the native cardiac valve annulus when the expandable anchoring member is in an expanded configuration. The apparatus also includes an expandable support member operably disposed within the main body portion of the expandable anchoring member, and a prosthetic cardiac valve secured within the expandable support member.

Description

    RELATED APPLICATION
  • This application claims priority from U.S. Provisional Application No. 61/173,782, filed Apr. 29, 2009, the subject matter of which is incorporated herein by reference.
  • TECHNICAL FIELD
  • The present invention relates generally to apparatus and methods for treating heart disease, and more particularly to self-expandable apparatus and methods for treating diseased cardiac valves.
  • BACKGROUND OF THE INVENTION
  • There are two atrioventricular (AV) valves in the heart; one on the left side of the heart and one on the right side of the heart. The left side AV valve is the mitral valve and the right side AV valve is the tricuspid valve. Both of these valves are subject damage and dysfunction that requires that the valve be repaired or replaced.
  • The mitral and tricuspid valves differ significantly in anatomy. While the annulus of the mitral valve is generally D-shaped, the annulus of the tricuspid valve is more circular. The effects of valvular dysfunction vary between the mitral valve and the tricuspid valve. Mitral valve regurgitation has more severe physiological consequences to the patient than does tricuspid valve regurgitation, a small amount of which is tolerable.
  • In mitral valve insufficiency, the valve leaflets do not fully close and a certain amount of blood leaks back into the left atrium when the left ventricle contracts. As a result, the heart has to work harder by pumping not only the regular volume of blood, but also the extra volume of blood that regurgitated back into the left atrium. The added workload creates an undue strain on the left ventricle. This strain can eventually wear out the heart and result in morbidity. Consequently, proper function of the mitral valve is critical to the pumping efficiency of the heart.
  • Mitral and tricuspid valve disease is traditionally treated by either surgical repair with an annuloplasty ring or surgical replacement with a valve prosthesis. Surgical valve replacement or repair, however, is often an exacting operation. The operation requires the use of a heart-lung machine for external circulation of the blood as the heart is stopped and then opened during the surgical intervention. Once the heart is opened, the artificial cardiac valves and/or annuloplasty rings are sewed in under direct vision.
  • Surgical repair of the AV valves exposes patients (i.e., elderly patients) to many risks. A minimally invasive procedure that could be performed under local anesthesia in the cardiac catheterization lab, rather than in cardiac surgery, could therefore offer tremendous benefits to these patients. Consequently, an apparatus for replacing a diseased AV valve using a minimally invasive approach would be very helpful in providing additional opportunities to treat patients with valvular insufficiency and/or end stage heart failure.
  • SUMMARY OF THE INVENTION
  • According to one aspect of the present invention, an apparatus is provided for replacing a native cardiac valve. The native cardiac valve has at least one leaflet and is surrounded by a native cardiac valve annulus. The native cardiac valve annulus has a superior aspect and an inferior aspect. The apparatus comprises a barbell-shaped, expandable anchoring member including a first end portion, a second end portion, and a main body portion extending between the end portions. The main body portion includes a channel defined by an inner surface and an outer surface. Each of the first and second end portions has a diameter greater than the diameter of the main body portion. The first and second end portions are sized to respectively contact the superior and inferior aspects of the native cardiac valve annulus when the expandable anchoring member is in an expanded configuration. The apparatus also includes an expandable support member operably disposed within the main body portion of the expandable anchoring member, and a prosthetic cardiac valve secured within the expandable support member.
  • According to another aspect of the present invention, a method is provided for replacing a native cardiac valve. The native cardiac valve has at least one leaflet and is surrounded by a native cardiac valve annulus. The native cardiac valve annulus has a superior aspect and an inferior aspect. One step of the method comprises providing an apparatus including a barbell-shaped expandable anchoring member, an expandable support member, and a prosthetic cardiac valve secured within the expandable support member. The expandable support member is secured within the expandable anchoring member. Each of the first and second end portions has a diameter greater than the diameter of the main body portion. The apparatus is placed into a delivery catheter, and the delivery catheter inserted into an atrial chamber. The delivery catheter is advanced until the delivery catheter is positioned within the native cardiac valve annulus. Next, the apparatus is removed from the delivery catheter so that the expandable anchoring member obtains an expanded configuration and the first and second end portions of the expandable anchoring member respectively contact the superior and inferior aspects of the native cardiac valve annulus and thereby secure the expandable anchoring member in the native cardiac annulus.
  • According to another aspect of the present invention, an apparatus is provided for replacing a native cardiac valve. The native cardiac valve has at least one leaflet and is surrounded by a native cardiac valve annulus. The native cardiac valve annulus has a superior aspect and an inferior aspect. The apparatus comprises an expandable support member, a prosthetic cardiac valve operably secured within the expandable support member, and a securing member operably connected to the expandable support member. The securing member comprises an elongated body member having a first end, a second end, and a main body portion extending between the first and second ends. The second end includes a first attachment member operably connected thereto for contacting the inferior aspect of the native cardiac valve annulus when the expandable support member is in an expanded configuration.
  • According to another aspect of the present invention, a method is provided for replacing a native cardiac valve. The native cardiac valve has at least one leaflet and is surrounded by a native cardiac valve annulus. The native cardiac valve annulus has a superior aspect and an inferior aspect. One step of the method comprises providing an apparatus including an expandable support member having a prosthetic cardiac valve secured therein and a securing member operably connected to the expandable support member. The securing member comprises an elongated body member having a first end, a second end, and a main body portion extending between the first and second ends. The second end includes a first attachment member operably connected thereto. The expandable anchoring member is placed into a delivery catheter, and the delivery catheter is then inserted into an atrial chamber. The delivery catheter is advanced until the delivery catheter is positioned within the native cardiac valve annulus. Next, the apparatus is removed from the delivery catheter so that the expandable support member obtains an expanded configuration and the first attachment member of the securing member contacts the inferior aspect of the native cardiac valve annulus and thereby secures the expandable support member in the native cardiac valve annulus.
  • According to another aspect of the present invention, an apparatus is provided for replacing a native cardiac valve. The native cardiac valve has at least one leaflet and is surrounded by a native cardiac valve annulus. The native cardiac valve annulus has a superior aspect and an inferior aspect. The apparatus comprises a securing member including an elongated body member having a first end, a second end, and a main body portion extending between the first and second ends. The second end includes a first attachment member operably connected thereto for contacting the inferior aspect of the native cardiac valve annulus when the expandable support member is in an expanded configuration. The apparatus also comprises a prosthetic valve operably secured to the securing member.
  • According to another aspect of the present invention, a method is provided for replacing a native cardiac valve. The native cardiac valve has at least one leaflet and is surrounded by a native cardiac valve annulus. The native cardiac valve annulus has a superior aspect and an inferior aspect. One step of the method includes providing an apparatus comprising a securing member and a prosthetic cardiac valve operably connected to the securing member. The securing member comprises an elongated body member having a first end, a second end, and a main body portion extending between the first and second ends. The second end includes a first attachment member operably connected thereto for contacting the inferior aspect of the native cardiac valve annulus when the expandable support member is in an expanded configuration. The apparatus is placed into a delivery catheter, and the delivery catheter is then inserted into an atrial chamber. The delivery catheter is advanced until the delivery catheter is positioned within the native cardiac valve annulus. Next, the apparatus is removed from the delivery catheter so that the prosthetic cardiac valve expands in place of the native cardiac valve and the first attachment member of the securing member contacts the inferior aspect of the native cardiac valve annulus and thereby secures the prosthetic cardiac valve in the native cardiac valve annulus.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The foregoing and other features of the present invention will become apparent to those skilled in the art to which the present invention relates upon reading the following description with reference to the accompanying drawings, in which:
  • FIG. 1A is a perspective view of an expandable anchoring member constructed in accordance with the present invention;
  • FIG. 1B is a perspective view of a prosthetic valve operably secured to an expandable support member;
  • FIG. 10 is a perspective view of an apparatus for replacing a native cardiac valve constructed in accordance with the present invention;
  • FIG. 1D is a cross-sectional view of the apparatus shown in FIG. 10;
  • FIG. 1E is a top plan view of the apparatus shown in FIG. 10;
  • FIG. 2 is a cross-sectional view of a human heart;
  • FIG. 3A is a perspective view showing an alternative embodiment of the expandable anchoring member in FIG. 1A;
  • FIG. 3B is a perspective view showing an alternative embodiment of the apparatus in FIG. 10;
  • FIG. 4 is a perspective view showing the apparatus of FIG. 10 being delivered to a native mitral valve;
  • FIG. 5 is a cross-sectional view showing the apparatus of FIG. 10 implanted in a native mitral valve;
  • FIG. 6A is a cross-sectional view showing another alternative embodiment of the apparatus in FIG. 10;
  • FIG. 6B is a cross-sectional view showing an alternative embodiment of the apparatus in FIG. 6A;
  • FIG. 6C is a cross-sectional view showing another alternative embodiment of the apparatus in FIG. 6A;
  • FIG. 6D is a cross-sectional view showing another alternative embodiment of the apparatus in FIG. 6A;
  • FIG. 6E is a cross-sectional view showing another alternative embodiment of the apparatus in FIG. 6A;
  • FIG. 7 is a perspective view showing the apparatus of FIG. 6A being delivered to a native mitral valve;
  • FIG. 8 is a cross-sectional view showing the apparatus of FIG. 6A implanted in a native mitral valve;
  • FIG. 9 is a cross-sectional view showing another alternative embodiment of the apparatus in FIG. 6A;
  • FIG. 10 is a cross-sectional view showing the apparatus of FIG. 9 implanted in a native mitral valve;
  • FIG. 11 is a cross-sectional view showing another alternative embodiment of the apparatus in FIG. 6A; and
  • FIG. 12 is a cross-sectional view showing the apparatus of FIG. 11 implanted in a native mitral valve.
  • DETAILED DESCRIPTION
  • The present invention relates generally to apparatus and methods for treating heart disease, and more particularly to self-expandable apparatus and methods for treating diseased cardiac valves. As representative of the present invention, FIGS. 1A-E illustrate one embodiment of an apparatus 10 for replacing a native cardiac valve. Although the present invention is described herein as being useful for treating a diseased mitral valve, it should be appreciated that other cardiac valves, such as the tricuspid valve, the pulmonary valve, and the aortic valve are also treatable according to the present invention.
  • FIG. 2 shows a human heart 12. The human heart 12 contains four chambers: the right and left atria 14 and 16 and the right and left ventricles 18 and 20. The thin-walled right atrium 14 receives deoxygenated blood from the superior vena cava 22, the inferior vena cava (not shown), and from the coronary sinus (not shown). The thin-walled left atrium 16 receives oxygenated blood from pulmonary veins 24. The right and left ventricles 18 and 20 pump oxygenated and deoxygenated blood, respectively, throughout the body, and the pocket-like pulmonary (not shown) and aortic 26 semilunar valves prevent reflux into the ventricles.
  • Atrial blood is pumped through the atrioventricular orifices, guarded by the 3-cusp tricuspid valve 28 on the right and the 2-cusp mitral valve 30 on the left. The mitral valve 30 is formed by two leaflets; namely, the anterior leaflet 32 and the posterior leaflet 34. The anterior leaflet 32 extends along a generally planar base of a D-shaped mitral annulus 36 (FIG. 5), while the posterior leaflet 34 (FIG. 2) extends arcuately around the curved portion of the annulus. The mitral and tricuspid valves 28 and 30 are secured to the papillary muscles 38 in the right and left ventricles 18 and 20 by tendinous chordae tendineae 40, and by the mitral annulus 36 and the tricuspid annulus (not shown in detail).
  • Referring again to FIGS. 1A-E, one embodiment of the present invention includes an apparatus 10 for replacing a native cardiac valve, such as a native mitral valve 30. As shown in FIG. 1A, the apparatus 10 comprises a barbell-shaped expandable anchoring member 42. The expandable anchoring member 42 includes a first end portion 44, a second end portion 46, and a main body portion 48 extending between the first and second end portions. The main body portion 48 includes a channel 50 defined by an inner surface 52 and an outer surface 54. The main body portion 48 has a generally cylindrical shape and is adapted to conform to the three-dimensional shape of a native cardiac valve annulus. It will be appreciated that the size and shape of the main body portion 48 may be varied as needed. For example, the diameter, circumference, and/or length of the main body portion 48 may be varied so that the expandable anchoring member 42 more readily conforms to the shape of a native cardiac valve annulus.
  • Each of the first and second end portions 44 and 46 of the expandable anchoring member 42 has a diameter that is greater than the diameter of the main body portion 48. As described in more detail below, the first and second end portions 44 and 46 are sized to respectively contact the superior and inferior aspects of a native cardiac valve annulus when the expandable anchoring member 42 is in an expanded configuration. The first and second end portions 44 and 46 can have identical or different configurations. As shown in FIG. 1A, for example, the first and second end portions 44 and 46 have a hemi-spherical shape with respect to an axial plane AP of the main body portion 48. Alternatively, the first and second end portions 44 and 46 of the expandable anchoring member 42 can have bulbous shape (FIGS. 3A-B).
  • The expandable anchoring member 42 is comprised of a single strand of a flexibly resilient material, such as Nitinol, stainless steel, or other suitable medical grade metals or plastics having shape memory characteristics. It will be appreciated, however, that the expandable anchoring member 42 can alternatively be comprised of multiple strands. Additionally, at least a portion of the expandable anchoring member 42 may be made from a bioabsorbable material including, for example, magnesium alloy, dendrimers, biopolymers such as thermoplastic starch, polyalctides, cellulose, and aliphatic aromatic copolyesters. The expandable anchoring member 42 may also be made of a radio-opaque material or include radio-opaque markers (not shown) to facilitate fluoroscopic visualization. The flexible and expandable properties of the expandable anchoring member 42 facilitate delivery of the apparatus 10 to a diseased native cardiac valve.
  • The apparatus 10 (FIG. 1C) additionally includes an expandable support member 56 (FIG. 1B) operably disposed within the main body portion 48 of the expandable anchoring member 42. The expandable support member 56 can be secured within the main body portion 48 using any one or combination of known fastening means (not shown), such as sutures, clips, pins, staples, adhesives, or the like. As shown in FIG. 1B, the expandable support member 56 includes oppositely disposed proximal and distal end portions 58 and 60, and a main body portion 62 extending between the end portions. The expandable support member 56 is both flexible and resilient and, as discussed in more detail below, can be made of a shape memory material such as Nitinol, stainless steel, or other suitable medical grade metals or plastics having shape memory characteristics.
  • The expandable support member 56 may additionally or optionally be made from a bioabsorbable material including, for example, magnesium alloy, dendrimers, biopolymers such as thermoplastic starch, polyalctides, cellulose, and aliphatic aromatic copolyesters. The expandable support member 56 may also be made of a radio-opaque material or include radio-opaque markers to facilitate fluoroscopic visualization. The flexible and expandable properties of the expandable support member 56 facilitate placement and movement of the expandable support member within the main body portion 48 of the expandable anchoring member 42.
  • The expandable support member 56 comprises a continuous series of W-shaped segments which collectively form a mesh-like configuration. It is contemplated, however, that other geometries may be used. The lower tips 64, as viewed in FIG. 1B, of the W-shaped segments form the distal end portion 60 of the expandable support member 56, and the upper tips 66 of the W-shaped segments form the proximal end portion 58 of the expandable support member. Other examples of expandable support members 56 which may be used as part of the present invention are disclosed in U.S. Patent Pub. No. 2007/0255389 A1, the entirety of which is hereby incorporated by reference.
  • As shown in FIGS. 1B-E, the expandable support member 56 also includes a prosthetic valve 68 operably secured therein. The prosthetic valve 68 is secured to the expandable support member 56 using any one or combination of known fastening means (not shown), such as sutures, pins, clips, staples, adhesives, or the like. Examples of prosthetic valves 68 are known in the art and can include, for instance, the prosthetic valves disclosed in U.S. Pat. No. 5,156,621, which is hereby incorporated by reference in its entirety.
  • The prosthetic valve 68 may be fixed and preserved using a variety of known methods. The use of chemical processes for the fixation and preservation of biological tissues have been described and are readily available in the art. For example, glutaraldehyde and other related aldehydes have seen widespread use in preparing cross-linked biological tissues. Glutaraldehyde is a five carbon aliphatic molecule with an aldehyde at each end of the chain, rendering it bifunctional. These aldehyde groups react under physiological conditions with primary amine groups on collagen molecules resulting in the cross-linking of collagen containing tissues. Methods for glutaraldehyde fixation of biological tissues have been extensively described and are well known in the art. In general, a biological tissue sample to be cross-linked is simply contacted with a glutaraldeyde solution for a duration effective to cause the desired degree of cross-linking within the biological tissue being treated.
  • Many variations and conditions have been applied to optimize glutaraldehyde fixation procedures. For example, lower concentrations have been found to be better in bulk tissue cross-linking compared to higher concentrations. It has been proposed that higher concentrations of glutaraldehyde may promote rapid surface cross-linking of the tissue, generating a barrier that impedes or prevents the further diffusion of glutaraldehdye into the tissue bulk. For most bioprosthesis applications, however, the tissue is treated with a relatively low concentration glutaraldehyde solution, e.g., typically between 0.1%-5%, for 24 hours or more to ensure optimum fixation. Various other combinations of glutaraldehyde concentrations and treatment times will also be suitable depending on the objectives for a given application. Examples of such other combinations include, but are not limited to, those disclosed in U.S. Pat. Nos. 6,547,827, 6,561,970, and 6,878,168, all of which are hereby incorporated by reference in their entireties.
  • In addition to bifunctional aldehydes, many other chemical fixation procedures have been described. For example, some methods have employed polyethers, polyepoxy compounds, diisocyanates, and azides. These and other approaches are available to the skilled artisan for treating biological tissues, and are suitable for cross-linking vascular graft tissue according to the present invention.
  • The prosthetic valve 68 may also be treated and preserved with a dry tissue valve procedure as described in U.S. Pat. No. 6,534,004, the entire contents of which are hereby incorporated by reference. Furthermore, the prosthetic valve 68 may be treated with anti-calcification solutions, such as XenoLogiX® treatment (Edwards Lifesciences, Irvine, Calif.), the SynerGraf® (CryoLife, Inc., Kennesaw, Ga.) treatment process, and/or anti-calcification agents, such as a-amino oleic acid.
  • The apparatus 10 may further include a layer (not shown) of biocompatible material covering at least a portion of the expandable anchoring member. The layer of biocompatible material may be synthetic, such as Dacron® (Invista, Wichita, Kans.), woven velour, polyurethane, polytetrafluoroethylene (PTFE), expanded PTFE, Gore-Tex® (W. L. Gore & Associates, Flagstaff, Ariz.), or heparin-coated fabric. Alternatively, the layer may be a biological material, such as bovine or equine pericardium, peritoneal tissue, an allograft, a homograft, a patient graft, or a cell-seeded tissue. The layer can cover either the inner surface 52 of the expandable anchoring member 42, the outer surface 54 of the expandable anchoring member, or a combination thereof. The layer may be attached around the entire circumference of the expandable anchoring member 42 or, alternatively, may be attached in pieces or interrupted sections to allow the expandable anchoring member to more easily expand and contract. By covering a portion of the expandable anchoring member 42 with a layer of biocompatible material, the hemocompatibility of the apparatus 10 may be improved.
  • At least a portion of the apparatus 10 may be treated with a therapeutic agent for eluting into cardiac tissue and/or blood. The therapeutic agent may be capable of treating a variety of pathological conditions including, but not limited to, thrombosis, stenosis and inflammation. Accordingly, the therapeutic agent may include at least one of an anticoagulant, an antioxidant, a fibrinolytic, a steroid, an anti-apoptotic agent, an anti-inflammatory agent, a receptor agonist or antagonist, and/or a hormone.
  • Optionally or additionally, the therapeutic agent may be capable of treating or preventing other diseases or disease processes, such as microbial infections. In these instances, the therapeutic agent may include an anti-microbial agent and/or a biological agent such as a cell, peptide or nucleic acid. The therapeutic agent can be simply linked to a surface of the apparatus 10, embedded and released from within polymer materials, such as a polymer matrix, or surrounded by and released through a carrier. The entire apparatus 10, or only a portion thereof, may be treated with the therapeutic agent. Additionally, different portions of the apparatus 10 may be treated with different therapeutic agents.
  • The apparatus 10 shown in FIGS. 1A-E and FIGS. 3A-B can be used to replace a diseased mitral valve 30, for example, using any one or combination of known surgical methods. As shown in FIGS. 4-5, for example, an apical puncture method can be used to respectively deliver the apparatus 10 shown in FIG. 10. It will be appreciated, however, that other percutaneous, transvascular, and/or open surgical procedures may be used to deliver the apparatus 10 to a diseased cardiac valve. For example, the apparatus 10 can be delivered to the tricuspid valve 28 via the pulmonary artery (not shown) or to the mitral valve 30 via the aortic valve 26. It will also be appreciated that the method of the present invention will typically entail gaining access to a beating heart 12; however, the present invention may also be used for intravascular stopped-heart access as well as stopped-heart open chest procedures.
  • FIG. 4 illustrates one step of an apical puncture method for delivering the apparatus 10 shown in FIG. 1C to a native cardiac valve, such as the mitral valve 30. One step of the method includes placing the apparatus 10 into a delivery catheter 70. As shown in FIG. 4, the delivery catheter 70 has proximal end portion 72 and a distal end portion 74. The delivery catheter 70 is shaped to facilitate insertion and removal of the apparatus 10 into and out of a puncture tool 76 (not shown in detail). The delivery catheter 70 may be constructed from a rigid, semi-rigid, or flexible material. For example, the delivery catheter 70 may be made of a flexible elastic material, such as a shape memory alloy, a super-elastic material (e.g., Nitinol, spring stainless steel, etc.), or plastic. Alternatively, the delivery catheter 70 may be made of a rigid material, such as hardened plastic, silicon, polyurethane, or the like.
  • Prior to placing the apparatus 10 into the delivery catheter 70, the dimensions of the native mitral valve 30 and the native mitral annulus 36 are determined. Various methods and devices for determining the dimensions of cardiac valves and cardiac valve annuluses are known in the art and include, for example, echocardiogram, computed tomography, magnetic resonance imaging, fluoroscopy, and angiography. After determining the dimensions of the native mitral valve 30 and the native mitral annulus 36, an appropriately-sized apparatus 10 is chosen for implantation. For example, the main body portion 48 of the expandable anchoring member 42 can be appropriately-sized so that the diameter of the main body portion corresponds to the diameter of the native mitral annulus 36. Additionally, the first and second end portions 44 and 46 of the expandable anchoring member 42 can also be appropriately-sized so that the first and second end portions respectively contact the superior and inferior aspects 78 and 80 of the mitral annulus 36 when the expandable anchoring member is in an expanded configuration.
  • After selecting an appropriately-sized apparatus 10, the puncture tool 76 is used to puncture the chest wall and extend through the apical portion of the left ventricle 20 into the left ventricular chamber. The delivery catheter 70 is then urged through the puncture tool 76 as shown in FIG. 4 so that the delivery catheter is positioned at a distal end portion 82 of the puncture tool. Both the puncture tool 76 and the delivery catheter 70 are then progressively withdrawn so that the first end portion 44 of the expandable anchoring member 42 expands to contact the superior aspect 78 of the native mitral annulus 36. Once the delivery catheter 70 and the puncture tool 76 have been completely withdrawn from the left ventricle 20, the main body portion 48 and the second end portion 46 of the expandable anchoring member 42 expand into the native mitral annulus 36 (FIG. 5). With the apparatus 10 securely positioned in the native mitral annulus 36, normal blood flow can resume through the prosthetic valve 68.
  • Another embodiment of the present invention is illustrated in FIGS. 6A-E. The apparatus 10 a is identically constructed as the apparatus 10 shown in FIGS. 1A-E, except where as described below. In FIGS. 6A-E, structures that are identical as structures in FIGS. 1A-E use the same reference numbers, whereas structures that are similar but not identical carry the suffix “a”.
  • An apparatus 10 a for replacing a native cardiac valve, such as a native mitral valve 30 can comprise an expandable support member 56 and a prosthetic cardiac 68 valve operably secured within the expandable support member. As shown in FIGS. 6A-E, the apparatus 10 a can further include a securing member 84 operably connected to the expandable support member 56. The securing member 84 can comprise an elongated body member 86 having a first end 88, a second end 90, and a main body portion 92 extending between the first and second ends. The securing member 84 can be operably secured to the expandable support member 56 using any one or combination of known fastening means (not shown), such as sutures, clips, pins, staples, adhesives, or the like.
  • The second end 90 of the elongated body member 84 can include a first attachment member 94 operably connected thereto for contacting the inferior aspect of the native cardiac valve annulus when the expandable support member 56 is in an expanded configuration. As shown in FIGS. 6A-E, the first end 88 of the elongated body member 86 can also include a second attachment member 96 operably connected thereto for contacting the superior aspect of the native cardiac valve annulus when the expandable support member 56 is in an expanded configuration. The first and second attachment members 94 and 96 can be made from any one or combination of flexibly resilient, medical grade materials, including, for example, Nitinol, stainless steel, or other suitable metals or plastics having shape memory characteristics.
  • The first and second attachment members 94 and 96 can have a variety of configurations. As shown in FIGS. 6A-C, for example, the first and second attachment members 94 and 96 can include flexible, rod-shaped members 98. The rod-shaped members 98 can be joined to or integrally formed with the elongated body member 86 so that the rod-shaped members can transition from a collapsed configuration (indicated by the dashed lines) to an expanded configuration. In the collapsed configuration, the rod-shaped members 98 can extend substantially parallel to the elongated body member 86. In the expanded configuration, the rod-shaped members 98 can extend substantially axial to the elongated body member 86. As described in more detail below, the rod-shaped members 98 located at the first and second ends 88 and 90 of the elongated body member 86 can respectively contact the superior and inferior aspects 78 and 80 of the mitral annulus 36 when the apparatus 10 a is in an expanded configuration.
  • As shown in FIGS. 6B-D, the first and second attachment members 94 and 96 can also comprise a windable coil 100. The windable coil 100 can be made of a flexible wire or rod capable of transitioning between an expanded configuration and a collapsed configuration. In the expanded configuration (indicated by the dashed lines), the windable coil 100 can obtain a substantially linear configuration so that the windable coil extends substantially parallel to the elongated body member 86. In the collapsed configuration (FIGS. 6B-D), the windable coil 100 can obtain a substantially circular configuration and extend substantially axial to the elongated body member 86. As described in more detail below, each of the windable coils 100 located at the first and second ends 88 and 90 of the elongated body member 86 can respectively contact the superior and inferior aspects 78 and 80 of a native mitral annulus 36 when the apparatus 10 a is in an expanded configuration.
  • The first and second attachment members 94 and 96 can additionally comprise an anchoring ring 102 (FIG. 6E). The anchoring ring 102 can be similarly or identically constructed as the first and second end portions 44 and 46 of the expandable anchoring member 42 shown in FIGS. 3A-B. In an expanded configuration, the anchoring ring 102 can have a bulbous shape and extend substantially axial to the elongated body member 86. In a collapsed configuration (indicated by dashed lines), the anchoring ring 102 can extend substantially parallel to the elongated body member 86. The anchoring ring 102 can be made of a flexible, mesh-like material having shape memory characteristics.
  • It will be appreciated that the apparatus 10 a shown in FIGS. 6A-E can additionally include a layer 104 (FIG. 8) of material that extends around all or a portion of the expandable support member 56. The layer 104 of material can be made of any one or combination of known biocompatible materials, some of which are described above. For example, the layer 104 can be made of PTFE or ePTFE. The layer 104 of material can function as a seal to prevent leakage of blood between the left atrium 16 and the left ventricle 20, for example, when the apparatus 10 a is implanted in a heart 12.
  • The apparatus 10 a shown in FIGS. 6A-E can be used to replace a native mitral valve 30, for example, using any one or combination of known surgical methods. As shown in FIG. 7, for example, an apical puncture method can be used to deliver the apparatus 10 a shown in FIG. 6A to a native mitral valve 30. It will be appreciated, however, that other percutaneous, transvascular, and/or open surgical methods may be used to deliver the apparatus 10 a to a native mitral valve 30. It will also be appreciated that the method of the present invention will typically entail gaining access to a beating heart 12; however, the present invention may also be used for intravascular stopped-heart access as well as stopped-heart open chest procedures.
  • The apparatus 10 a shown in FIG. 6A can be delivered to a native mitral valve 30 using an apical puncture method similar or identical to the apical puncture method described above. Briefly, one step of the method can include placing the apparatus 10 a into a delivery catheter 70. Prior to placing the apparatus 10 a into the delivery catheter 70, the dimensions of the native mitral valve 30 and the native mitral annulus 36 can be determined. After selecting an apparatus 10 a whose dimensions correspond to the dimensions of the native mitral valve 30 and the native mitral annulus 36, a puncture tool 76 can be used to puncture the chest wall. The puncture tool 76 can then be extended through the apical portion of the left ventricle 20 into the left ventricular chamber. Next, the delivery catheter 70 can be urged through the puncture tool 76 as shown in FIG. 7 so that the delivery catheter is positioned at a distal end portion 82 of the puncture tool.
  • Both the puncture tool 76 and the delivery catheter 70 can then be progressively withdrawn from the left ventricle 20 so that the expandable support member 56 can expand into contact with the native mitral annulus 36, and the rod-shaped members 98 can transition from the collapsed configuration to the expanded configuration. As the delivery catheter 70 and the puncture tool 76 are completely removed from the left ventricle 20, the rod-shaped members 98 located at the first and second ends 88 and 90 of the elongated body members 86 can respectively contact the superior and inferior aspects 78 and 80 of the mitral annulus 36 and thereby secure the apparatus 10 a in the native mitral annulus (FIG. 8). With the apparatus 10 a securely positioned in the native mitral annulus 36, normal blood flow can resume through the prosthetic valve 68. Another embodiment of the present invention is illustrated in FIG. 9.
  • The apparatus 10 b is identically constructed as the apparatus 10 a shown in FIGS. 6A-E, except where as described below. In FIG. 9, structures that are identical as structures in FIGS. 6A-E use the same reference numbers, whereas structures that are similar but not identical carry the suffix “b”.
  • An apparatus 10 b for replacing a native cardiac valve, such as a mitral valve 30 can comprise an expandable support member 56 and a prosthetic valve 68 operably secured within the expandable support member. As shown in FIG. 9, the apparatus 10 b can further include a securing member 84 operably connected to the expandable support member 56. The securing member 84 can comprise an elongated body member 86 having a first end 88, a second end 90, and a main body portion 92 extending between the first and second ends. The securing member 84 can be operably secured to the expandable support member 56 using any one or combination of known fastening means (not shown), such as sutures, clips, pins, staples, adhesives, or the like.
  • The second end 90 of the elongated body member 86 can also include a first attachment member 94 operably connected thereto for embedding into the annular tissue at the inferior aspect of a native cardiac valve annulus. As shown in FIG. 9, the first attachment member 94 can include at least one rod-shaped puncturing member 106. The puncturing member 106 can have a fixed length or, alternatively, the puncturing member can have a compressible, spring-like configuration (not shown). The puncturing member 106 can have a needle- or barb-like shape to facilitate penetration of the puncturing member into annular tissue.
  • The apparatus 10 b is capable of transitioning between a collapsed configuration and an expanded configuration. As shown in FIG. 9, the puncturing member 106 can extend substantially axial to the elongated body member 86 in the expanded configuration. In the collapsed configuration (indicated by the dashed lines), the puncturing member 106 can extend substantially parallel to the elongated body member 86. As described in more detail below, the puncturing member 106 can be used to secure the apparatus 10 b in a native cardiac valve annulus.
  • The apparatus 10 b shown in FIG. 9 can be delivered to a native cardiac valve, such as a mitral valve 30 using an apical puncture method similar or identical to the apical puncture method described above. Briefly, one step of the method can include placing the apparatus 10 b into a delivery catheter 70. Prior to placing the apparatus 10 b into the delivery catheter 70, the dimensions of the native mitral valve 30 and the native mitral annulus 36 can be determined. After selecting an apparatus 10 b whose dimensions correspond to the dimensions of the native mitral valve 30 and the native mitral annulus 36, the puncture tool 76 can be used to puncture the chest wall. The puncture tool 76 can then be extended through the apical portion of the left ventricle 20 into the left ventricular chamber. Next, the delivery catheter 70 can be urged through the puncture tool 76 so that the delivery catheter is positioned at a distal end portion 82 of the puncture tool (not shown).
  • Both the puncture tool 76 and the delivery catheter 70 can then be progressively withdrawn from the left ventricle 20 so that the expandable support member 56 expands into contact with the native mitral annulus 36. As the delivery catheter 70 and the puncture tool 76 are completely removed from the left ventricle 20, each of the puncture members 106 can transition from the collapsed configuration to the expanded configuration. In the expanded configuration, each of the puncture members 106 can penetrate into the annular tissue at the inferior aspect 80 of the native mitral annulus 36 and thereby secure the apparatus 10 b in the native mitral annulus (FIG. 10). With the apparatus 10 b securely positioned in the native mitral annulus 36, normal blood flow can resume through the prosthetic valve 68.
  • Another embodiment of the present invention is illustrated in FIG. 11. The apparatus 10 c is identically constructed as the apparatus 10 a shown in FIGS. 6A-E, except where as described below. In FIG. 11, structures that are identical as structures in FIGS. 6A-E use the same reference numbers, whereas structures that are similar but not identical carry the suffix “c”.
  • An apparatus 10 c for replacing a native cardiac valve, such as a mitral valve 30 can comprise a prosthetic valve 68 operably secured to a securing member 84. The securing member 84 can comprise an elongated body member 86 having a first end 88, a second end 90, and a main body portion 92 extending between the first and second ends. The securing member 84 can be operably secured to the prosthetic valve 68 using any one or combination of known fastening means (not shown), such as sutures, clips, pins, staples, adhesives, or the like.
  • The second end 90 of the elongated body member 86 can include a first attachment member 94 operably connected thereto for contacting the inferior aspect of a native cardiac valve annulus when the apparatus 10 c is in an expanded configuration. As shown in FIG. 11, the first end 88 of the elongated body member 86 can also include a second attachment member 96 operably connected thereto for contacting the superior aspect of a native cardiac valve annulus when the apparatus 10 c is in an expanded configuration. The first and second attachment members 94 and 96 can be made from any one or combination of flexibly resilient, medical grade materials, including, for example, Nitinol, stainless steel, or other suitable metals or plastics having shape memory characteristics.
  • The first and second attachment members 94 and 96 can have a variety of configurations. As shown in FIG. 11, for example, the first and second attachment members 94 and 96 can include flexible, rod-shaped members 98. It will be appreciated, however, that the first and second attachment members 94 and 96 can also comprise any one or combination of the structures illustrated in FIGS. 6A-E. The rod-shaped members 98 can be joined to or integrally formed with the elongated body member 86 so that the rod-shaped members can transition from a collapsed configuration (indicated by dashed lines) to an expanded configuration. In the collapsed configuration, the rod-shaped members 98 can extend substantially parallel to the elongated body member 86. In the expanded configuration, the rod-shaped members 98 can extend substantially axial to the elongated body member 86. As described in more detail below, the rod-shaped members 98 located at the first and second ends 88 and 90 of the elongated body member 86 can respectively contact the superior and inferior aspects 78 and 80 of the mitral annulus 36 when the apparatus 10 c is in an expanded configuration.
  • The apparatus 10 c shown in FIG. 11 can be used to replace a native cardiac valve, such as a native mitral valve 30 using an apical puncture method similar or identical to the apical puncture method described above. Briefly, one step of the method can include placing the apparatus 10 c into a delivery catheter 70. Prior to placing the apparatus 10 c into the delivery catheter 70, the dimensions of the native mitral valve 30 and the native mitral annulus 36 can be determined. After selecting an apparatus 10 c whose dimensions correspond to the dimensions of the native mitral valve 30 and the native mitral annulus 36, a puncture tool 76 can be used to puncture the chest wall. The puncture tool 76 can then be extended through the apical portion of the left ventricle 20 into the left ventricular chamber. Next, the delivery catheter 70 can be urged through the puncture tool 76 so that the delivery catheter is positioned at a distal end portion 82 of the puncture tool (not shown).
  • Both the puncture tool 76 and the delivery catheter 70 can then be progressively withdrawn from the left ventricle 20 so that prosthetic valve 68 expands into contact with the native mitral annulus 36, and the rod-shaped members 98 located at the first end 88 of each of the elongated body members 86 transitions from the collapsed configuration to the expanded configuration. As the delivery catheter 70 and the puncture tool 76 are completely removed from the left ventricle 20, the rod-shaped members 98 located at the first and second ends 88 and 90 of each of the elongated body members 86 can respectively contact the superior and inferior aspects 78 and 80 of the mitral annulus 36, thereby securing the apparatus 10 c in the native mitral annulus (FIG. 12). With the apparatus 10 c securely positioned in the native mitral annulus 36, normal blood flow can resume through the prosthetic valve 68.
  • From the above description of the invention, those skilled in the art will perceive improvements, changes and modifications. For example, it will be appreciated that the methods of the present invention can include implanting an expandable anchoring member 42 or an expandable support member 56, without a prosthetic valve 68 attached therein, in a native cardiac valve annulus. After the expandable anchoring member 42 or the expandable support member 56 is securely positioned in the native cardiac valve annulus, a prosthetic valve 68 can then be secured therein using any one or combination of known fastening means. Such improvements, changes and modifications are within the skill of the art and are intended to be covered by the appended claims.

Claims (25)

1. An apparatus for replacing a native cardiac valve, the native cardiac valve having at least one leaflet and being surrounded by a native cardiac valve annulus, the native cardiac valve annulus having a superior aspect and an inferior aspect, said apparatus comprising:
a barbell-shaped expandable anchoring member including a first end portion, a second end portion, and a main body portion extending between said end portions, said main body portion including a channel defined by an inner surface and an outer surface, each of said first and second end portions having a diameter greater than the diameter of said main body portion, said first and second end portions being sized to respectively contact the superior and inferior aspects of the native cardiac valve annulus when said expandable anchoring member is in an expanded configuration;
an expandable support member operably disposed within said main body portion of said expandable anchoring member; and
a prosthetic cardiac valve secured within said expandable support member.
2. The apparatus of claim 1, wherein said expandable anchoring member is comprised of a single strand of a flexibly resilient material.
3. The apparatus of claim 1, wherein each of said first and second end portions has a hemi-spherical shape with respect to an axial plane of the said main body portion of said expandable anchoring member.
4. The apparatus of claim 1, wherein each of said first and second end portions has a bulbous shape with respect to an axial plane of the said main body portion of said expandable anchoring member.
5. A method for replacing a native cardiac valve, the native cardiac valve having at least one leaflet and being surrounded by a native cardiac valve annulus, the native cardiac valve annulus having a superior aspect and an inferior aspect, said method comprising the steps of:
providing an apparatus comprising a barbell-shaped expandable anchoring member, an expandable support member, and a prosthetic cardiac valve secured within the expandable support member, the expandable support member being secured within the expandable anchoring member, each of the first and second end portions having a diameter greater than the diameter of the main body portion;
placing the apparatus into a delivery catheter;
inserting the delivery catheter into an atrial chamber;
advancing the delivery catheter until the delivery catheter is positioned within the native cardiac valve annulus; and
removing the apparatus from the delivery catheter so that the expandable anchoring member obtains an expanded configuration and the first and second end portions of the expandable anchoring member respectively contact the superior and inferior aspects of the native cardiac valve annulus and thereby secure the expandable anchoring member in the native cardiac annulus.
6. An apparatus for replacing a native cardiac valve, the native cardiac valve having at least one leaflet and being surrounded by a native cardiac valve annulus, the native cardiac valve annulus having a superior aspect and an inferior aspect, said apparatus comprising:
an expandable support member;
a prosthetic cardiac valve operably secured within said expandable support member; and
a securing member operably connected to said expandable support member, said securing member comprising an elongated body member having a first end, a second end, and a main body portion extending between said first and second ends, said second end including a first attachment member operably connected thereto for contacting the inferior aspect of the native cardiac valve annulus when said expandable support member is in an expanded configuration.
7. The apparatus of claim 6, wherein said first attachment member includes at least one rod-shaped puncturing member for embedding into the tissue of the native cardiac valve annulus when said expandable support member is in an expanded configuration.
8. The apparatus of claim 6, wherein said first end of said securing member includes a second attachment member operably connected thereto for contacting the superior aspect of the native cardiac valve annulus when said expandable support member is in an expanded configuration.
9. The apparatus of claim 8, wherein each of said first and second attachment members has a loop-shaped configuration that extends substantially axial to said elongated body member of said securing member when said expandable support member is in an expanded configuration.
10. The apparatus of claim 8, wherein each of said first and second attachment members comprises a flexible, rod-shaped member that extends substantially axial to said elongated body member of said securing member when said expandable support member is in an expanded configuration.
11. The apparatus of claim 8, wherein each of said first and second attachment members comprises a windable coil that extends substantially axial to said elongated body member of said securing member when said expandable support member is in an expanded configuration.
12. The apparatus of claim 8, wherein said first attachment member comprises an anchoring ring and said second attachment member comprises a windable coil, said anchoring ring and said windable coil extending substantially axial to said elongated body member of said securing member when said expandable support member is in an expanded configuration.
13. The apparatus of claim 8, wherein said first attachment member comprises a flexible, rod-shaped member and said second attachment member comprises a windable coil, said rod-shaped member and said windable coil extending substantially axial to said elongated body member of said securing member when said expandable support member is in an expanded configuration.
14. The apparatus of claim 6, wherein a layer of biocompatible material is connected to a portion of said elongated body member of said securing member to prevent or mitigate leakage of blood flow between said expandable support member and the native cardiac valve annulus.
15. A method for replacing a native cardiac valve, the native cardiac valve having at least one leaflet and being surrounded by a native cardiac valve annulus, the native cardiac valve annulus having a superior aspect and an inferior aspect, said method comprising the steps of:
providing an apparatus comprising an expandable support member having a prosthetic cardiac valve secured therein and a securing member operably connected to the expandable support member, the securing member comprising an elongated body member having a first end, a second end, and a main body portion extending between the first and second ends, the second end including a first attachment member operably connected thereto;
placing the expandable anchoring member into a delivery catheter;
inserting the apparatus into an atrial chamber;
advancing the delivery catheter until the delivery catheter is positioned within the native cardiac valve annulus; and
removing the apparatus from the delivery catheter so that the expandable support member obtains an expanded configuration and the first attachment member of the securing member contacts the inferior aspect of the native cardiac valve annulus and thereby secures the expandable support member in the native cardiac valve annulus.
16. An apparatus for replacing a native cardiac valve, the native cardiac valve having at least one leaflet and being surrounded by a native cardiac valve annulus, the native cardiac valve annulus having a superior aspect and an inferior aspect, said apparatus comprising:
a securing member comprising an elongated body member having a first end, a second end, and a main body portion extending between said first and second ends, said second end including a first attachment member operably connected thereto for contacting the inferior aspect of the native cardiac valve annulus when said expandable support member is in an expanded configuration; and
a prosthetic valve operably secured to said securing member.
17. The apparatus of claim 16, wherein said first attachment member includes at least one rod-shaped puncturing member for embedding into the tissue of the native cardiac valve annulus when said expandable support member is in an expanded configuration.
18. The apparatus of claim 16, wherein said first end of said securing member includes a second attachment member operably connected thereto for contacting the superior aspect of the native cardiac valve annulus when said expandable support member is in an expanded configuration.
19. The apparatus of claim 18, wherein each of said first and second attachment members has a loop-shaped configuration that extends substantially axial to said elongated body member of said securing member when said expandable support member is in an expanded configuration.
20. The apparatus of claim 18, wherein each of said first and second attachment members comprises a flexible, rod-shaped member that extends substantially axial to said elongated body member of said securing member when said expandable support member is in an expanded configuration.
21. The apparatus of claim 18, wherein each of said first and second attachment members comprises a windable coil that extends substantially axial to said elongated body member of said securing member when said expandable support member is in an expanded configuration.
22. The apparatus of claim 18, wherein said first attachment member comprises an anchoring ring and said second attachment member comprises a windable coil, said anchoring ring and said windable coil extending substantially axial to said elongated body member of said securing member when said expandable support member is in an expanded configuration.
23. The apparatus of claim 18, wherein said first attachment member comprises a flexible, rod-shaped member and said second attachment member comprises a windable coil, said rod-shaped member and said windable coil extending substantially axial to said elongated body member of said securing member when said expandable support member is in an expanded configuration.
24. The apparatus of claim 16, wherein a layer of biocompatible material is connected to a portion of said elongated body member of said securing member to prevent or mitigate leakage of blood flow between said expandable support member and the native cardiac valve annulus.
25. A method for replacing a native cardiac valve, the native cardiac valve having at least one leaflet and being surrounded by a native cardiac valve annulus, the native cardiac valve annulus having a superior aspect and an inferior aspect, said method comprising the steps of:
providing an apparatus comprising a securing member and a prosthetic cardiac valve operably connected to the securing member, the securing member comprising an elongated body member having a first end, a second end, and a main body portion extending between the first and second ends, the second end including a first attachment member operably connected thereto for contacting the inferior aspect of the native cardiac valve annulus when the expandable support member is in an expanded configuration;
placing the apparatus into a delivery catheter;
inserting the delivery catheter into an atrial chamber;
advancing the delivery catheter until the delivery catheter is positioned within the native cardiac valve annulus; and
removing the apparatus from the delivery catheter so that the prosthetic cardiac valve expands in place of the native cardiac valve and the first attachment member of the securing member contacts the inferior aspect of the native cardiac valve annulus and thereby secures the prosthetic cardiac valve in the native cardiac valve annulus.
US12/769,593 2005-02-18 2010-04-28 Apparatus and method for replacing a diseased cardiac valve Abandoned US20100312333A1 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
US12/769,593 US20100312333A1 (en) 2009-04-29 2010-04-28 Apparatus and method for replacing a diseased cardiac valve
AU2010266210A AU2010266210B2 (en) 2009-07-02 2010-07-01 Apparatus and method for replacing a diseased cardiac valve
PCT/US2010/040786 WO2011002996A2 (en) 2009-07-02 2010-07-01 Apparatus and method for replacing a diseased cardiac valve
CA2767035A CA2767035C (en) 2009-07-02 2010-07-01 Apparatus and method for replacing a diseased cardiac valve
EP10794766.5A EP2448522A4 (en) 2009-07-02 2010-07-01 Apparatus and method for replacing a diseased cardiac valve
US12/828,991 US8685086B2 (en) 2006-02-18 2010-07-01 Apparatus and method for replacing a diseased cardiac valve
US14/230,216 US10010416B2 (en) 2006-02-18 2014-03-31 Apparatus and method for replacing a diseased cardiac valve
AU2014280916A AU2014280916B2 (en) 2009-07-02 2014-12-23 Apparatus and method for replacing a diseased cardiac valve
US16/025,977 US10939999B2 (en) 2005-02-18 2018-07-02 Apparatus and method for replacing a diseased cardiac valve
US17/067,580 US20210161657A1 (en) 2009-04-29 2020-10-09 Apparatus and method for replacing a diseased cardiac valve
US17/556,830 US20220110748A1 (en) 2009-04-29 2021-12-20 Apparatus and method for replacing a diseased cardiac valve

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17378209P 2009-04-29 2009-04-29
US12/769,593 US20100312333A1 (en) 2009-04-29 2010-04-28 Apparatus and method for replacing a diseased cardiac valve

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/357,485 Continuation-In-Part US20060195183A1 (en) 2005-02-18 2006-02-18 Apparatus and methods for replacing a cardiac valve

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12/828,991 Continuation-In-Part US8685086B2 (en) 2005-02-18 2010-07-01 Apparatus and method for replacing a diseased cardiac valve
US17/067,580 Continuation US20210161657A1 (en) 2009-04-29 2020-10-09 Apparatus and method for replacing a diseased cardiac valve

Publications (1)

Publication Number Publication Date
US20100312333A1 true US20100312333A1 (en) 2010-12-09

Family

ID=42299145

Family Applications (3)

Application Number Title Priority Date Filing Date
US12/769,593 Abandoned US20100312333A1 (en) 2005-02-18 2010-04-28 Apparatus and method for replacing a diseased cardiac valve
US17/067,580 Pending US20210161657A1 (en) 2009-04-29 2020-10-09 Apparatus and method for replacing a diseased cardiac valve
US17/556,830 Pending US20220110748A1 (en) 2009-04-29 2021-12-20 Apparatus and method for replacing a diseased cardiac valve

Family Applications After (2)

Application Number Title Priority Date Filing Date
US17/067,580 Pending US20210161657A1 (en) 2009-04-29 2020-10-09 Apparatus and method for replacing a diseased cardiac valve
US17/556,830 Pending US20220110748A1 (en) 2009-04-29 2021-12-20 Apparatus and method for replacing a diseased cardiac valve

Country Status (6)

Country Link
US (3) US20100312333A1 (en)
EP (2) EP2429455B8 (en)
AU (1) AU2010241596B2 (en)
CA (1) CA2760461C (en)
NZ (2) NZ624106A (en)
WO (1) WO2010127041A1 (en)

Cited By (168)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120016464A1 (en) * 2010-07-19 2012-01-19 Jacques Seguin Cardiac valve repair system and methods of use
US20120316643A1 (en) * 2006-11-13 2012-12-13 Keraenen Olli Device and Method For Improving Function Of Heart Valve
WO2013059743A1 (en) * 2011-10-19 2013-04-25 Foundry Newco Xii, Inc. Devices, systems and methods for heart valve replacement
EP2641570A1 (en) * 2012-03-22 2013-09-25 Brecker, Stephen Replacement heart valve
WO2013158608A1 (en) * 2012-04-19 2013-10-24 Caisson Interventional, LLC Heart valve assembly systems and methods
EP2695586A1 (en) * 2012-08-10 2014-02-12 Sorin Group Italia S.r.l. A valve prosthesis and kit
US8790398B2 (en) 2002-01-04 2014-07-29 Colibri Heart Valve Llc Percutaneously implantable replacement heart valve device and method of making same
US8795356B2 (en) 2009-04-15 2014-08-05 Cardiaq Valve Technologies, Inc. Vascular implant
US20140236291A1 (en) * 2012-04-19 2014-08-21 Caisson Interventional Llc Valve replacement systems and methods
US20140243954A1 (en) * 2013-02-27 2014-08-28 Donald Shannon Transcatheter mitral valve prosthesis
US20140257476A1 (en) * 2011-03-21 2014-09-11 Matteo Montorfano Disk-Based Valve Apparatus and Method for the Treatment of Valve Dysfunction
US8845717B2 (en) 2011-01-28 2014-09-30 Middle Park Medical, Inc. Coaptation enhancement implant, system, and method
US8888843B2 (en) 2011-01-28 2014-11-18 Middle Peak Medical, Inc. Device, system, and method for transcatheter treatment of valve regurgitation
US8894702B2 (en) 2008-09-29 2014-11-25 Cardiaq Valve Technologies, Inc. Replacement heart valve and method
US8911455B2 (en) 2008-10-01 2014-12-16 Cardiaq Valve Technologies, Inc. Delivery system for vascular implant
US20140371844A1 (en) * 2013-06-18 2014-12-18 St. Jude Medical, Cardiology Division, Inc. Transcatheter mitral valve and delivery system
WO2015009503A3 (en) * 2013-07-17 2015-03-19 Cephea Valve Technologies, Inc. System and method for cardiac valve repair and replacement
US20150112433A1 (en) * 2013-10-23 2015-04-23 Caisson Interventional Llc Methods and systems for heart valve therapy
US9023100B2 (en) 2009-09-29 2015-05-05 Cardiaq Valve Technologies, Inc. Replacement heart valves, delivery devices and methods
US9034033B2 (en) 2011-10-19 2015-05-19 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9089422B2 (en) * 2008-01-24 2015-07-28 Medtronic, Inc. Markers for prosthetic heart valves
US20150216685A1 (en) * 2012-08-10 2015-08-06 Abiomed, Inc. Graft anchor devices, systems and methods
US20150238313A1 (en) * 2014-02-21 2015-08-27 Mitral Valve Technologies, Sarl Devices, systems and methods for delivering a prosthetic mitral valve and anchoring device
US9119738B2 (en) 2010-06-28 2015-09-01 Colibri Heart Valve Llc Method and apparatus for the endoluminal delivery of intravascular devices
US9125740B2 (en) 2011-06-21 2015-09-08 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US20150257880A1 (en) * 2014-03-11 2015-09-17 Highlife Sas Transcatheter valve prosthesis
US20150257882A1 (en) * 2014-03-11 2015-09-17 Highlife Sas Transcatheter valve prosthesis
WO2015173609A1 (en) 2014-05-14 2015-11-19 Sorin Group Italia S.R.L. Implant device and implantation kit
EP2793751A4 (en) * 2011-12-21 2016-01-13 Univ Pennsylvania Platforms for mitral valve replacement
EP2982336A1 (en) 2014-08-04 2016-02-10 Alvimedica Tibb Ürünler San. Ve Dis Tic. A.S. Mitral valve prosthesis, particularly suitable for transcatheter implantation
USD755384S1 (en) 2014-03-05 2016-05-03 Edwards Lifesciences Cardiaq Llc Stent
WO2016083551A1 (en) * 2014-11-26 2016-06-02 Konstantinos Spargias Transcatheter prosthetic heart valve and delivery system
US9358108B2 (en) 2011-09-12 2016-06-07 Highlife Sas Transcatheter valve prosthesis
US20160158003A1 (en) * 2014-12-09 2016-06-09 Dan Wallace Replacement cardiac valves and methods of use and manufacture
US9375312B2 (en) 2010-07-09 2016-06-28 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US20160199177A1 (en) * 2013-08-12 2016-07-14 Landon H. Tompkins Apparatus and methods for implanting a replacement heart valve
US9421098B2 (en) 2010-12-23 2016-08-23 Twelve, Inc. System for mitral valve repair and replacement
US9480560B2 (en) 2009-09-29 2016-11-01 Edwards Lifesciences Cardiaq Llc Method of securing an intralumenal frame assembly
CN106102659A (en) * 2014-03-14 2016-11-09 安东尼欧·法兰西斯寇·纳维斯·费侯 There is support and the support bringing device of mechanicalness or biological heart valve for Wicresoft's valve replacement surgery
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
US9579198B2 (en) 2012-03-01 2017-02-28 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
US9592121B1 (en) 2015-11-06 2017-03-14 Middle Peak Medical, Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
WO2017083413A1 (en) 2015-11-10 2017-05-18 Edwards Lifesciences Corporation Transcatheter heart valve for replacing natural mitral valve
US9655722B2 (en) 2011-10-19 2017-05-23 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
CN106714734A (en) * 2014-08-21 2017-05-24 爱德华兹生命科学公司 Dual-flange prosthetic valve frame
US9662206B2 (en) 2011-09-12 2017-05-30 Highlife Sas Transcatheter valve prosthesis
US9681951B2 (en) 2013-03-14 2017-06-20 Edwards Lifesciences Cardiaq Llc Prosthesis with outer skirt and anchors
US20170196685A1 (en) * 2011-07-29 2017-07-13 Carnegie Mellon University Artificial valved conduits for cardiac reconstructive procedures and methods for their production
US9713529B2 (en) 2011-04-28 2017-07-25 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9724083B2 (en) 2013-07-26 2017-08-08 Edwards Lifesciences Cardiaq Llc Systems and methods for sealing openings in an anatomical wall
CN107028685A (en) * 2011-10-19 2017-08-11 托尔福公司 Artificial heart valve film device, artificial mitral valve and related systems and methods
US9730791B2 (en) 2013-03-14 2017-08-15 Edwards Lifesciences Cardiaq Llc Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US9737400B2 (en) 2010-12-14 2017-08-22 Colibri Heart Valve Llc Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets
US9750607B2 (en) 2014-10-23 2017-09-05 Caisson Interventional, LLC Systems and methods for heart valve therapy
US9750605B2 (en) 2014-10-23 2017-09-05 Caisson Interventional, LLC Systems and methods for heart valve therapy
US9763780B2 (en) 2011-10-19 2017-09-19 Twelve, Inc. Devices, systems and methods for heart valve replacement
US9770329B2 (en) 2010-05-05 2017-09-26 Neovasc Tiara Inc. Transcatheter mitral valve prosthesis
US9895225B2 (en) 2012-03-23 2018-02-20 Sorin Group Italia S.R.L. Collapsible valve prosthesis
US9974647B2 (en) 2014-06-12 2018-05-22 Caisson Interventional, LLC Two stage anchor and mitral valve assembly
US9993338B2 (en) 2008-06-20 2018-06-12 Edwards Lifesciences Corporation Methods for retaining a prosthetic heart valve
US10016275B2 (en) 2012-05-30 2018-07-10 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US10016272B2 (en) 2014-09-12 2018-07-10 Mitral Valve Technologies Sarl Mitral repair and replacement devices and methods
US20180193138A1 (en) * 2012-07-28 2018-07-12 Tendyne Holdings, Inc. Multi-component designs for heart valve retrieval device, sealing structures and stent assembly
US20180206985A1 (en) * 2017-01-23 2018-07-26 Spencer NOE Replacement mitral valves
US10034747B2 (en) 2015-08-27 2018-07-31 Medtronic Vascular, Inc. Prosthetic valve system having a docking component and a prosthetic valve component
US10039637B2 (en) 2015-02-11 2018-08-07 Edwards Lifesciences Corporation Heart valve docking devices and implanting methods
US10052198B2 (en) 2013-08-14 2018-08-21 Mitral Valve Technologies Sarl Coiled anchor for supporting prosthetic heart valve, prosthetic heart valve, and deployment device
US20180271654A1 (en) * 2015-02-05 2018-09-27 Mitraltech Ltd. Prosthetic Valve with Axially-Sliding Frames
US10111747B2 (en) 2013-05-20 2018-10-30 Twelve, Inc. Implantable heart valve devices, mitral valve repair devices and associated systems and methods
US10123874B2 (en) 2017-03-13 2018-11-13 Middle Peak Medical, Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
US10130464B2 (en) 2010-03-05 2018-11-20 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves
US10143552B2 (en) 2015-05-14 2018-12-04 Cephea Valve Technologies, Inc. Replacement mitral valves
US10143550B2 (en) 2013-08-08 2018-12-04 Sorin Group Italia S.R.L. Heart valve prosthesis
EP3010446B1 (en) 2013-06-19 2018-12-19 AGA Medical Corporation Collapsible valve having paravalvular leak protection
US10166098B2 (en) 2013-10-25 2019-01-01 Middle Peak Medical, Inc. Systems and methods for transcatheter treatment of valve regurgitation
US10195028B2 (en) 2013-09-10 2019-02-05 Edwards Lifesciences Corporation Magnetic retaining mechanisms for prosthetic valves
US10226339B2 (en) 2012-01-31 2019-03-12 Mitral Valve Technologies Sarl Mitral valve docking devices, systems and methods
US10226330B2 (en) 2013-08-14 2019-03-12 Mitral Valve Technologies Sarl Replacement heart valve apparatus and methods
US10231834B2 (en) 2015-02-09 2019-03-19 Edwards Lifesciences Corporation Low profile transseptal catheter and implant system for minimally invasive valve procedure
US20190083246A1 (en) * 2017-09-19 2019-03-21 Cardiovalve Ltd. Prosthetic valve with protective sleeve around an outlet rim
US10238490B2 (en) 2015-08-21 2019-03-26 Twelve, Inc. Implant heart valve devices, mitral valve repair devices and associated systems and methods
US10238489B2 (en) 2011-12-21 2019-03-26 Edwards Lifesciences Corporation Anchoring device and method for replacing or repairing a heart valve
US10251635B2 (en) 2014-06-24 2019-04-09 Middle Peak Medical, Inc. Systems and methods for anchoring an implant
EP2484309B1 (en) 2011-02-02 2019-04-10 Shlomo Gabbay Heart valve prosthesis
US20190110894A1 (en) * 2015-06-12 2019-04-18 St. Jude Medical, Cardiology Division, Inc. Heart Valve Repair and Replacement
US10265166B2 (en) 2015-12-30 2019-04-23 Caisson Interventional, LLC Systems and methods for heart valve therapy
US10265172B2 (en) 2016-04-29 2019-04-23 Medtronic Vascular, Inc. Prosthetic heart valve devices with tethered anchors and associated systems and methods
US10357360B2 (en) 2015-02-05 2019-07-23 Cardiovalve Ltd. Prosthetic valve with aligned inner and outer frames
US10357361B2 (en) 2016-09-15 2019-07-23 Edwards Lifesciences Corporation Heart valve pinch devices and delivery systems
EP2861186B1 (en) 2012-06-19 2019-07-24 Boston Scientific Scimed, Inc. Replacement heart valve
US10363130B2 (en) 2016-02-05 2019-07-30 Edwards Lifesciences Corporation Devices and systems for docking a heart valve
US10368990B2 (en) 2017-01-23 2019-08-06 Cephea Valve Technologies, Inc. Replacement mitral valves
US10376361B2 (en) 2011-08-05 2019-08-13 Cardiovalve Ltd. Techniques for percutaneous mitral valve replacement and sealing
JP2019141714A (en) * 2013-03-15 2019-08-29 トゥエルヴ, インコーポレイテッド Prosthetic heart valve device, prosthetic mitral valve and associated system and method
US10426614B2 (en) 2016-08-01 2019-10-01 Cardiovalve Ltd. Minimally-invasive delivery systems
US10433961B2 (en) 2017-04-18 2019-10-08 Twelve, Inc. Delivery systems with tethers for prosthetic heart valve devices and associated methods
US10449039B2 (en) 2015-03-19 2019-10-22 Caisson Interventional, LLC Systems and methods for heart valve therapy
US10463479B2 (en) 2016-08-26 2019-11-05 Edwards Lifesciences Corporation Heart valve docking coils and systems
USD867595S1 (en) 2017-02-01 2019-11-19 Edwards Lifesciences Corporation Stent
US10478303B2 (en) 2017-03-13 2019-11-19 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
US10492908B2 (en) 2014-07-30 2019-12-03 Cardiovalve Ltd. Anchoring of a prosthetic valve
US10500048B2 (en) 2014-06-18 2019-12-10 Polares Medical Inc. Mitral valve implants for the treatment of valvular regurgitation
US10500047B2 (en) 2010-07-23 2019-12-10 Edwards Lifesciences Corporation Methods for delivering prosthetic valves to native heart valves
EP3380042B1 (en) 2015-11-23 2019-12-11 TricPer SAS Assembly for replacing the tricuspid atrioventricular valve
US10512456B2 (en) 2010-07-21 2019-12-24 Cardiovalve Ltd. Techniques for percutaneous mitral valve replacement and sealing
US10531954B2 (en) 2015-03-20 2020-01-14 St. Jude Medical, Cardiology Division, Inc. Mitral valve loading tool
US10531866B2 (en) 2016-02-16 2020-01-14 Cardiovalve Ltd. Techniques for providing a replacement valve and transseptal communication
US10537426B2 (en) 2017-08-03 2020-01-21 Cardiovalve Ltd. Prosthetic heart valve
US10548726B2 (en) 2009-12-08 2020-02-04 Cardiovalve Ltd. Rotation-based anchoring of an implant
US10575948B2 (en) 2017-08-03 2020-03-03 Cardiovalve Ltd. Prosthetic heart valve
US10575950B2 (en) 2017-04-18 2020-03-03 Twelve, Inc. Hydraulic systems for delivering prosthetic heart valve devices and associated methods
US10583002B2 (en) 2013-03-11 2020-03-10 Neovasc Tiara Inc. Prosthetic valve with anti-pivoting mechanism
US10588745B2 (en) 2016-06-20 2020-03-17 Medtronic Vascular, Inc. Modular valve prosthesis, delivery system, and method of delivering and deploying a modular valve prosthesis
US10610357B2 (en) 2016-10-10 2020-04-07 Peca Labs, Inc. Transcatheter stent and valve assembly
US10624740B2 (en) 2016-05-13 2020-04-21 St. Jude Medical, Cardiology Division, Inc. Mitral valve delivery device
US10631982B2 (en) 2013-01-24 2020-04-28 Cardiovale Ltd. Prosthetic valve and upstream support therefor
US10646333B2 (en) 2013-10-24 2020-05-12 Medtronic, Inc. Two-piece valve prosthesis with anchor stent and valve component
US10646338B2 (en) 2017-06-02 2020-05-12 Twelve, Inc. Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods
US10653524B2 (en) 2017-03-13 2020-05-19 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
US10702385B2 (en) 2011-08-05 2020-07-07 Cardiovalve Ltd. Implant for heart valve
US10702378B2 (en) 2017-04-18 2020-07-07 Twelve, Inc. Prosthetic heart valve device and associated systems and methods
US10709591B2 (en) 2017-06-06 2020-07-14 Twelve, Inc. Crimping device and method for loading stents and prosthetic heart valves
USD890333S1 (en) 2017-08-21 2020-07-14 Edwards Lifesciences Corporation Heart valve docking coil
US10722359B2 (en) 2016-08-26 2020-07-28 Edwards Lifesciences Corporation Heart valve docking devices and systems
US10729541B2 (en) 2017-07-06 2020-08-04 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10786352B2 (en) 2017-07-06 2020-09-29 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10792151B2 (en) 2017-05-11 2020-10-06 Twelve, Inc. Delivery systems for delivering prosthetic heart valve devices and associated methods
US10799343B2 (en) 2015-02-12 2020-10-13 Medtronic, Inc. Integrated valve assembly and method of delivering and deploying an integrated valve assembly
US10813749B2 (en) 2016-12-20 2020-10-27 Edwards Lifesciences Corporation Docking device made with 3D woven fabric
US10828150B2 (en) 2016-07-08 2020-11-10 Edwards Lifesciences Corporation Docking station for heart valve prosthesis
US10828157B2 (en) 2011-09-12 2020-11-10 Highlife Sas Transcatheter valve prosthesis
US10842619B2 (en) 2017-05-12 2020-11-24 Edwards Lifesciences Corporation Prosthetic heart valve docking assembly
US10849746B2 (en) 2015-05-14 2020-12-01 Cephea Valve Technologies, Inc. Cardiac valve delivery devices and systems
US10856982B2 (en) 2017-09-19 2020-12-08 St. Jude Medical, Cardiology Division, Inc. Transapical mitral valve delivery system
US10856975B2 (en) 2016-08-10 2020-12-08 Cardiovalve Ltd. Prosthetic valve with concentric frames
US10888421B2 (en) 2017-09-19 2021-01-12 Cardiovalve Ltd. Prosthetic heart valve with pouch
CN112220505A (en) * 2014-09-09 2021-01-15 奥特鲁泰克控股有限公司 Flow regulating device in heart
US10940000B2 (en) 2016-12-16 2021-03-09 Edwards Lifesciences Corporation Deployment systems, tools, and methods for delivering an anchoring device for a prosthetic valve
US11000370B2 (en) 2016-03-02 2021-05-11 Peca Labs, Inc. Expandable implantable conduit
US11013600B2 (en) 2017-01-23 2021-05-25 Edwards Lifesciences Corporation Covered prosthetic heart valve
US11065111B2 (en) 2016-12-20 2021-07-20 Edwards Lifesciences Corporation Systems and mechanisms for deploying a docking device for a replacement heart valve
US11185406B2 (en) 2017-01-23 2021-11-30 Edwards Lifesciences Corporation Covered prosthetic heart valve
US11202704B2 (en) 2011-10-19 2021-12-21 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US11246704B2 (en) 2017-08-03 2022-02-15 Cardiovalve Ltd. Prosthetic heart valve
US20220054266A1 (en) * 2012-08-13 2022-02-24 Medtronic, Inc. Heart valve prosthesis
US11291547B2 (en) 2011-08-05 2022-04-05 Cardiovalve Ltd. Leaflet clip with collars
US11291540B2 (en) 2017-06-30 2022-04-05 Edwards Lifesciences Corporation Docking stations for transcatheter valves
US11311399B2 (en) 2017-06-30 2022-04-26 Edwards Lifesciences Corporation Lock and release mechanisms for trans-catheter implantable devices
US11331187B2 (en) 2016-06-17 2022-05-17 Cephea Valve Technologies, Inc. Cardiac valve delivery devices and systems
US11337810B2 (en) 2013-11-22 2022-05-24 Edwards Lifesciences Corporation Valvular insufficiency repair device and method
US11382746B2 (en) 2017-12-13 2022-07-12 Cardiovalve Ltd. Prosthetic valve and delivery tool therefor
US11395726B2 (en) 2017-09-11 2022-07-26 Incubar Llc Conduit vascular implant sealing device for reducing endoleaks
US11413172B2 (en) 2015-09-01 2022-08-16 Medtronic, Inc. Stent assemblies including passages to provide blood flow to coronary arteries and methods of delivering and deploying such stent assemblies
US11464634B2 (en) 2020-12-16 2022-10-11 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation with secondary anchors
US11471282B2 (en) 2019-03-19 2022-10-18 Shifamed Holdings, Llc Prosthetic cardiac valve devices, systems, and methods
US11504231B2 (en) 2018-05-23 2022-11-22 Corcym S.R.L. Cardiac valve prosthesis
US11628060B2 (en) * 2009-11-05 2023-04-18 The Trustees Of The University Of Pennsylvania Valve prosthesis
US11633277B2 (en) 2018-01-10 2023-04-25 Cardiovalve Ltd. Temperature-control during crimping of an implant
US11648122B2 (en) 2017-10-19 2023-05-16 Cardiovalve Ltd. Techniques for use with prosthetic valve leaflets
US11654023B2 (en) 2017-01-23 2023-05-23 Edwards Lifesciences Corporation Covered prosthetic heart valve
US11653910B2 (en) 2010-07-21 2023-05-23 Cardiovalve Ltd. Helical anchor implantation
US11672657B2 (en) 2018-10-05 2023-06-13 Shifamed Holdings, Llc Prosthetic cardiac valve devices, systems, and methods
US11707355B2 (en) 2020-05-28 2023-07-25 Medtronic, Inc. Modular heart valve prosthesis
US11759321B2 (en) 2021-06-25 2023-09-19 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
US11793633B2 (en) 2017-08-03 2023-10-24 Cardiovalve Ltd. Prosthetic heart valve
US11833034B2 (en) * 2016-01-13 2023-12-05 Shifamed Holdings, Llc Prosthetic cardiac valve devices, systems, and methods
US11918461B2 (en) 2023-05-15 2024-03-05 Edwards Lifesciences Corporation Methods for treating a deficient native mitral valve

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8845722B2 (en) 2009-08-03 2014-09-30 Shlomo Gabbay Heart valve prosthesis and method of implantation thereof
EP2478868A1 (en) * 2011-01-25 2012-07-25 The Provost, Fellows, Foundation Scholars, and the other Members of Board, of the College of the Holy and Undivided Trinity of Queen Elizabeth Implant device
DE102014102721A1 (en) * 2014-02-28 2015-09-03 Highlife Sas Transcatheter valve prosthesis
DE102011054172A1 (en) * 2011-09-12 2013-03-14 Highlife Sas Transcatheter valve prosthesis
US9439763B2 (en) 2013-02-04 2016-09-13 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
EP2967849A4 (en) * 2013-03-12 2017-01-18 St. Jude Medical, Cardiology Division, Inc. Self-actuating sealing portions for paravalvular leak protection
US9398951B2 (en) * 2013-03-12 2016-07-26 St. Jude Medical, Cardiology Division, Inc. Self-actuating sealing portions for paravalvular leak protection
KR20220104302A (en) * 2013-03-15 2022-07-26 네비게이트 카디악 스트럭쳐스, 인크. Catheter-guided replacement valves apparatus and methods
US20140330370A1 (en) * 2013-05-03 2014-11-06 Robert G. Matheny Prosthetic Valve Delivery and Mounting Apparatus and System
CN103705274B (en) * 2013-12-20 2017-03-29 先健科技(深圳)有限公司 Plugging device
JP7006940B2 (en) 2016-01-29 2022-01-24 ニオバスク ティアラ インコーポレイテッド Artificial valve to avoid blockage of outflow
WO2018090148A1 (en) 2016-11-21 2018-05-24 Neovasc Tiara Inc. Methods and systems for rapid retraction of a transcatheter heart valve delivery system
EP3672530A4 (en) 2017-08-25 2021-04-14 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
JP7260930B2 (en) 2018-11-08 2023-04-19 ニオバスク ティアラ インコーポレイテッド Ventricular deployment of a transcatheter mitral valve prosthesis
EP3946163A4 (en) 2019-04-01 2022-12-21 Neovasc Tiara Inc. Controllably deployable prosthetic valve
WO2020210652A1 (en) 2019-04-10 2020-10-15 Neovasc Tiara Inc. Prosthetic valve with natural blood flow
CA3140925A1 (en) 2019-05-20 2020-11-26 Neovasc Tiara Inc. Introducer with hemostasis mechanism
WO2020257643A1 (en) 2019-06-20 2020-12-24 Neovasc Tiara Inc. Low profile prosthetic mitral valve

Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5156621A (en) * 1988-03-22 1992-10-20 Navia Jose A Stentless bioprosthetic cardiac valve
US5234447A (en) * 1990-08-28 1993-08-10 Robert L. Kaster Side-to-end vascular anastomotic staple apparatus
US5370685A (en) * 1991-07-16 1994-12-06 Stanford Surgical Technologies, Inc. Endovascular aortic valve replacement
US5840081A (en) * 1990-05-18 1998-11-24 Andersen; Henning Rud System and method for implanting cardiac valves
US5957949A (en) * 1997-05-01 1999-09-28 World Medical Manufacturing Corp. Percutaneous placement valve stent
US6197054B1 (en) * 1998-09-01 2001-03-06 Sulzer Carbomedics Inc. Sutureless cuff for heart valves
US6231561B1 (en) * 1999-09-20 2001-05-15 Appriva Medical, Inc. Method and apparatus for closing a body lumen
US6251135B1 (en) * 1997-08-01 2001-06-26 Schneider (Usa) Inc Radiopaque marker system and method of use
US6338740B1 (en) * 1999-01-26 2002-01-15 Edwards Lifesciences Corporation Flexible heart valve leaflets
US20020055774A1 (en) * 2000-09-07 2002-05-09 Liddicoat John R. Fixation band for affixing a prosthetic heart valve to tissue
US6534004B2 (en) * 1998-05-14 2003-03-18 The Cleveland Clinic Foundation Processing of implantable animal tissues for dry storage
US20030069646A1 (en) * 2001-10-09 2003-04-10 Scimed Life Systems, Inc. Medical stent with a valve and related methods of manufacturing
US6547827B2 (en) * 1998-09-21 2003-04-15 Edwards Lifesciences Corporation Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
US6561970B1 (en) * 1994-07-29 2003-05-13 Edwards Lifesciences Corporation Methods for treating implantable biological tissues to mitigate the calcification thereof and bioprosthetic articles treated by such methods
US20040093060A1 (en) * 1999-11-17 2004-05-13 Jacques Seguin Prosthetic valve for transluminal delivery
US20040122516A1 (en) * 2002-12-20 2004-06-24 Fogarty Thomas J. Biologically implantable prosthesis and methods of using the same
US20040236411A1 (en) * 2001-07-19 2004-11-25 The Cleveland Clinic Foundation Prosthetic cardiac valve and method for making same
US6878168B2 (en) * 2002-01-03 2005-04-12 Edwards Lifesciences Corporation Treatment of bioprosthetic tissues to mitigate post implantation calcification
US20050137689A1 (en) * 2003-12-23 2005-06-23 Sadra Medical, A Delware Corporation Retrievable heart valve anchor and method
US20050182486A1 (en) * 2004-02-13 2005-08-18 Shlomo Gabbay Support apparatus and heart valve prosthesis for sutureless implantation
US20050203616A1 (en) * 1996-12-31 2005-09-15 Alain Cribier Valve prosthesis for implantation in body channels
US20070100435A1 (en) * 2003-04-24 2007-05-03 Cook Incorporated Artificial prostheses with preferred geometries
US20070162107A1 (en) * 2003-12-23 2007-07-12 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US20070255389A1 (en) * 2006-04-26 2007-11-01 The Cleveland Clinic Foundation Apparatus and method for treating cardiovascular diseases
US20080208327A1 (en) * 2007-02-27 2008-08-28 Rowe Stanton J Method and apparatus for replacing a prosthetic valve

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2253449T3 (en) * 2001-06-08 2006-06-01 Rex Medical, Lp VASCULAR DEVICE WITH VALVE TO APPROXIMATE VASCULAR WALLS.
US20030118560A1 (en) * 2001-12-20 2003-06-26 Kelly Sheila J. Composite biocompatible matrices
US8828078B2 (en) * 2003-12-23 2014-09-09 Sadra Medical, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
EP1883375B1 (en) * 2005-05-24 2016-12-07 Edwards Lifesciences Corporation Rapid deployment prosthetic heart valve
US8663312B2 (en) * 2005-05-27 2014-03-04 Hlt, Inc. Intravascular cuff
EP2583640B1 (en) * 2006-02-16 2022-06-22 Venus MedTech (HangZhou), Inc. Minimally invasive replacement heart valve
EP1849440A1 (en) * 2006-04-28 2007-10-31 Younes Boudjemline Vascular stents with varying diameter
JP5021988B2 (en) * 2006-09-06 2012-09-12 サンデン株式会社 Power transmission device
US8105375B2 (en) * 2007-01-19 2012-01-31 The Cleveland Clinic Foundation Method for implanting a cardiovascular valve
WO2009091968A1 (en) * 2008-01-18 2009-07-23 Med Institute, Inc. Intravascular device attachment system having struts

Patent Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5156621A (en) * 1988-03-22 1992-10-20 Navia Jose A Stentless bioprosthetic cardiac valve
US5840081A (en) * 1990-05-18 1998-11-24 Andersen; Henning Rud System and method for implanting cardiac valves
US5234447A (en) * 1990-08-28 1993-08-10 Robert L. Kaster Side-to-end vascular anastomotic staple apparatus
US5370685A (en) * 1991-07-16 1994-12-06 Stanford Surgical Technologies, Inc. Endovascular aortic valve replacement
US6561970B1 (en) * 1994-07-29 2003-05-13 Edwards Lifesciences Corporation Methods for treating implantable biological tissues to mitigate the calcification thereof and bioprosthetic articles treated by such methods
US20050203616A1 (en) * 1996-12-31 2005-09-15 Alain Cribier Valve prosthesis for implantation in body channels
US5957949A (en) * 1997-05-01 1999-09-28 World Medical Manufacturing Corp. Percutaneous placement valve stent
US6251135B1 (en) * 1997-08-01 2001-06-26 Schneider (Usa) Inc Radiopaque marker system and method of use
US6534004B2 (en) * 1998-05-14 2003-03-18 The Cleveland Clinic Foundation Processing of implantable animal tissues for dry storage
US6197054B1 (en) * 1998-09-01 2001-03-06 Sulzer Carbomedics Inc. Sutureless cuff for heart valves
US6547827B2 (en) * 1998-09-21 2003-04-15 Edwards Lifesciences Corporation Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
US6338740B1 (en) * 1999-01-26 2002-01-15 Edwards Lifesciences Corporation Flexible heart valve leaflets
US6231561B1 (en) * 1999-09-20 2001-05-15 Appriva Medical, Inc. Method and apparatus for closing a body lumen
US20040093060A1 (en) * 1999-11-17 2004-05-13 Jacques Seguin Prosthetic valve for transluminal delivery
US20020055774A1 (en) * 2000-09-07 2002-05-09 Liddicoat John R. Fixation band for affixing a prosthetic heart valve to tissue
US20040236411A1 (en) * 2001-07-19 2004-11-25 The Cleveland Clinic Foundation Prosthetic cardiac valve and method for making same
US20030069646A1 (en) * 2001-10-09 2003-04-10 Scimed Life Systems, Inc. Medical stent with a valve and related methods of manufacturing
US6878168B2 (en) * 2002-01-03 2005-04-12 Edwards Lifesciences Corporation Treatment of bioprosthetic tissues to mitigate post implantation calcification
US20040122516A1 (en) * 2002-12-20 2004-06-24 Fogarty Thomas J. Biologically implantable prosthesis and methods of using the same
US20070100435A1 (en) * 2003-04-24 2007-05-03 Cook Incorporated Artificial prostheses with preferred geometries
US20050137689A1 (en) * 2003-12-23 2005-06-23 Sadra Medical, A Delware Corporation Retrievable heart valve anchor and method
US20070162107A1 (en) * 2003-12-23 2007-07-12 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US20050182486A1 (en) * 2004-02-13 2005-08-18 Shlomo Gabbay Support apparatus and heart valve prosthesis for sutureless implantation
US20070255389A1 (en) * 2006-04-26 2007-11-01 The Cleveland Clinic Foundation Apparatus and method for treating cardiovascular diseases
US20080208327A1 (en) * 2007-02-27 2008-08-28 Rowe Stanton J Method and apparatus for replacing a prosthetic valve

Cited By (481)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9554898B2 (en) 2002-01-04 2017-01-31 Colibri Heart Valve Llc Percutaneous prosthetic heart valve
US8900294B2 (en) 2002-01-04 2014-12-02 Colibri Heart Valve Llc Method of controlled release of a percutaneous replacement heart valve
US9186248B2 (en) 2002-01-04 2015-11-17 Colibri Heart Valve Llc Percutaneously implantable replacement heart valve device and method of making same
US9610158B2 (en) 2002-01-04 2017-04-04 Colibri Heart Valve Llc Percutaneously implantable replacement heart valve device and method of making same
US8790398B2 (en) 2002-01-04 2014-07-29 Colibri Heart Valve Llc Percutaneously implantable replacement heart valve device and method of making same
US9125739B2 (en) 2002-01-04 2015-09-08 Colibri Heart Valve Llc Percutaneous replacement heart valve and a delivery and implantation system
US8734507B2 (en) * 2006-11-13 2014-05-27 Medtentia International Ltd. Oy Device and method for improving function of heart valve
US20120316643A1 (en) * 2006-11-13 2012-12-13 Keraenen Olli Device and Method For Improving Function Of Heart Valve
US9089422B2 (en) * 2008-01-24 2015-07-28 Medtronic, Inc. Markers for prosthetic heart valves
US10966827B2 (en) 2008-06-20 2021-04-06 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves
US10722355B2 (en) 2008-06-20 2020-07-28 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves
US9993338B2 (en) 2008-06-20 2018-06-12 Edwards Lifesciences Corporation Methods for retaining a prosthetic heart valve
US8894702B2 (en) 2008-09-29 2014-11-25 Cardiaq Valve Technologies, Inc. Replacement heart valve and method
US9456896B2 (en) 2008-09-29 2016-10-04 Edwards Lifesciences Cardiaq Llc Body cavity prosthesis
US9339377B2 (en) 2008-09-29 2016-05-17 Edwards Lifesciences Cardiaq Llc Body cavity prosthesis
US9597183B2 (en) 2008-10-01 2017-03-21 Edwards Lifesciences Cardiaq Llc Delivery system for vascular implant
US8911455B2 (en) 2008-10-01 2014-12-16 Cardiaq Valve Technologies, Inc. Delivery system for vascular implant
US8795356B2 (en) 2009-04-15 2014-08-05 Cardiaq Valve Technologies, Inc. Vascular implant
US9333073B2 (en) 2009-04-15 2016-05-10 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery method
US9333074B2 (en) 2009-04-15 2016-05-10 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery system
US9339379B2 (en) 2009-04-15 2016-05-17 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery system
US9339378B2 (en) 2009-04-15 2016-05-17 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery system
US9339380B2 (en) 2009-04-15 2016-05-17 Edwards Lifesciences Cardiaq Llc Vascular implant
US9585747B2 (en) 2009-04-15 2017-03-07 Edwards Lifesciences Cardiaq Llc Vascular implant
US9480560B2 (en) 2009-09-29 2016-11-01 Edwards Lifesciences Cardiaq Llc Method of securing an intralumenal frame assembly
US9023100B2 (en) 2009-09-29 2015-05-05 Cardiaq Valve Technologies, Inc. Replacement heart valves, delivery devices and methods
US10166097B2 (en) 2009-09-29 2019-01-01 Edwards Lifesciences Cardiaq Llc Replacement heart valve and method
US9730790B2 (en) 2009-09-29 2017-08-15 Edwards Lifesciences Cardiaq Llc Replacement valve and method
US9949827B2 (en) 2009-09-29 2018-04-24 Edwards Lifesciences Cardiaq Llc Replacement heart valves, delivery devices and methods
US11864993B2 (en) 2009-11-05 2024-01-09 The Trustees Of The University Of Pennsylvania Valve prosthesis
US11628060B2 (en) * 2009-11-05 2023-04-18 The Trustees Of The University Of Pennsylvania Valve prosthesis
US11141268B2 (en) 2009-12-08 2021-10-12 Cardiovalve Ltd. Prosthetic heart valve with upper and lower skirts
US11351026B2 (en) 2009-12-08 2022-06-07 Cardiovalve Ltd. Rotation-based anchoring of an implant
US10660751B2 (en) 2009-12-08 2020-05-26 Cardiovalve Ltd. Prosthetic heart valve with upper skirt
US10548726B2 (en) 2009-12-08 2020-02-04 Cardiovalve Ltd. Rotation-based anchoring of an implant
US11839541B2 (en) 2009-12-08 2023-12-12 Cardiovalve Ltd. Prosthetic heart valve with upper skirt
US10610359B2 (en) 2009-12-08 2020-04-07 Cardiovalve Ltd. Folding ring prosthetic heart valve
US10130464B2 (en) 2010-03-05 2018-11-20 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves
US10568736B2 (en) 2010-03-05 2020-02-25 Edward Lifesciences Corporation Retaining mechanisms for prosthetic valves
US11890187B2 (en) 2010-03-05 2024-02-06 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves
US11419720B2 (en) 2010-05-05 2022-08-23 Neovasc Tiara Inc. Transcatheter mitral valve prosthesis
US11432924B2 (en) 2010-05-05 2022-09-06 Neovasc Tiara Inc. Transcatheter mitral valve prosthesis
US9770329B2 (en) 2010-05-05 2017-09-26 Neovasc Tiara Inc. Transcatheter mitral valve prosthesis
US10449042B2 (en) 2010-05-05 2019-10-22 Neovasc Tiara Inc. Transcatheter mitral valve prosthesis
US9119738B2 (en) 2010-06-28 2015-09-01 Colibri Heart Valve Llc Method and apparatus for the endoluminal delivery of intravascular devices
US11883283B2 (en) 2010-07-09 2024-01-30 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US11259922B2 (en) 2010-07-09 2022-03-01 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US11446140B2 (en) 2010-07-09 2022-09-20 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US9375312B2 (en) 2010-07-09 2016-06-28 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US11311377B2 (en) 2010-07-09 2022-04-26 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US9931206B2 (en) 2010-07-09 2018-04-03 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US11259921B2 (en) 2010-07-09 2022-03-01 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US20120016464A1 (en) * 2010-07-19 2012-01-19 Jacques Seguin Cardiac valve repair system and methods of use
US10383724B2 (en) 2010-07-19 2019-08-20 Bmeye B.V. Cardiac valve repair system and methods of use
US10813752B2 (en) 2010-07-19 2020-10-27 Bmeye B.V. Cardiac valve repair system and methods of use
US8657872B2 (en) * 2010-07-19 2014-02-25 Jacques Seguin Cardiac valve repair system and methods of use
US11504234B2 (en) 2010-07-19 2022-11-22 Bmeye B.V. Cardiac valve repair system and methods of use
US10743988B2 (en) 2010-07-19 2020-08-18 Bmeye B.V. Cardiac valve repair system and methods of use
US9629716B2 (en) 2010-07-19 2017-04-25 Bmeye B.V. Cardiac valve repair system and methods of use
US10512456B2 (en) 2010-07-21 2019-12-24 Cardiovalve Ltd. Techniques for percutaneous mitral valve replacement and sealing
US11653910B2 (en) 2010-07-21 2023-05-23 Cardiovalve Ltd. Helical anchor implantation
US10925595B2 (en) 2010-07-21 2021-02-23 Cardiovalve Ltd. Valve prosthesis configured for deployment in annular spacer
US10531872B2 (en) 2010-07-21 2020-01-14 Cardiovalve Ltd. Valve prosthesis configured for deployment in annular spacer
US11426155B2 (en) 2010-07-21 2022-08-30 Cardiovalve Ltd. Helical anchor implantation
US10500047B2 (en) 2010-07-23 2019-12-10 Edwards Lifesciences Corporation Methods for delivering prosthetic valves to native heart valves
US11696827B2 (en) 2010-07-23 2023-07-11 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves
US9737400B2 (en) 2010-12-14 2017-08-22 Colibri Heart Valve Llc Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets
US10973632B2 (en) 2010-12-14 2021-04-13 Colibri Heart Valve Llc Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets
US9421098B2 (en) 2010-12-23 2016-08-23 Twelve, Inc. System for mitral valve repair and replacement
US9770331B2 (en) 2010-12-23 2017-09-26 Twelve, Inc. System for mitral valve repair and replacement
US10517725B2 (en) 2010-12-23 2019-12-31 Twelve, Inc. System for mitral valve repair and replacement
US11571303B2 (en) 2010-12-23 2023-02-07 Twelve, Inc. System for mitral valve repair and replacement
US10470883B2 (en) 2011-01-28 2019-11-12 Polares Medical Inc. Coaptation enhancement implant, system, and method
US11648120B2 (en) 2011-01-28 2023-05-16 Polares Medical Inc. Coaptation enhancement implant, system, and method
US11648119B2 (en) 2011-01-28 2023-05-16 Polares Medical Inc. Coaptation enhancement implant, system, and method
US8888843B2 (en) 2011-01-28 2014-11-18 Middle Peak Medical, Inc. Device, system, and method for transcatheter treatment of valve regurgitation
US10512542B2 (en) 2011-01-28 2019-12-24 Polares Medical Inc. Device, system, and method for transcatheter treatment of valve regurgitation
US11413145B2 (en) 2011-01-28 2022-08-16 Polares Medical Inc. Coaptation enhancement implant, system, and method
US8845717B2 (en) 2011-01-28 2014-09-30 Middle Park Medical, Inc. Coaptation enhancement implant, system, and method
US9610163B2 (en) 2011-01-28 2017-04-04 Middle Peak Medical, Inc. Coaptation enhancement implant, system, and method
US11678986B2 (en) 2011-01-28 2023-06-20 Polares Medical Inc. Device, system, and method for transcatheter treatment of valve regurgitation
US11419722B2 (en) 2011-01-28 2022-08-23 Polares Medical Inc. Device, system, and method for transcatheter treatment of valve regurgitation
US11426279B2 (en) 2011-01-28 2022-08-30 Polares Medical Inc. Coaptation enhancement implant, system, and method
US9592118B2 (en) 2011-01-28 2017-03-14 Middle Peak Medical, Inc. Device, system, and method for transcatheter treatment of valve regurgitation
EP2484309B1 (en) 2011-02-02 2019-04-10 Shlomo Gabbay Heart valve prosthesis
US11903825B2 (en) 2011-02-23 2024-02-20 Edwards Lifesciences Cardiaq Llc Replacement heart valve and method
US10779938B2 (en) 2011-02-23 2020-09-22 Edwards Lifesciences Cardiaq Llc Replacement heart valve and method
US10456255B2 (en) * 2011-03-21 2019-10-29 Cephea Valve Technologies, Inc. Disk-based valve apparatus and method for the treatment of valve dysfunction
US20140257476A1 (en) * 2011-03-21 2014-09-11 Matteo Montorfano Disk-Based Valve Apparatus and Method for the Treatment of Valve Dysfunction
US9713529B2 (en) 2011-04-28 2017-07-25 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US10034750B2 (en) 2011-06-21 2018-07-31 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US9572662B2 (en) 2011-06-21 2017-02-21 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10028827B2 (en) 2011-06-21 2018-07-24 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US11712334B2 (en) 2011-06-21 2023-08-01 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US11523900B2 (en) 2011-06-21 2022-12-13 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US9585751B2 (en) 2011-06-21 2017-03-07 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US9579196B2 (en) 2011-06-21 2017-02-28 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10751173B2 (en) 2011-06-21 2020-08-25 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US9125740B2 (en) 2011-06-21 2015-09-08 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US20170196685A1 (en) * 2011-07-29 2017-07-13 Carnegie Mellon University Artificial valved conduits for cardiac reconstructive procedures and methods for their production
US11672651B2 (en) 2011-07-29 2023-06-13 Carnegie Mellon University Artificial valved conduits for cardiac reconstructive procedures and methods for their production
US10624737B2 (en) * 2011-07-29 2020-04-21 Carnegie Mellon University Artificial valved conduits for cardiac reconstructive procedures and methods for their production
US11517429B2 (en) 2011-08-05 2022-12-06 Cardiovalve Ltd. Apparatus for use at a heart valve
US10376361B2 (en) 2011-08-05 2019-08-13 Cardiovalve Ltd. Techniques for percutaneous mitral valve replacement and sealing
US11517436B2 (en) 2011-08-05 2022-12-06 Cardiovalve Ltd. Implant for heart valve
US11291546B2 (en) 2011-08-05 2022-04-05 Cardiovalve Ltd. Leaflet clip with collars
US11864995B2 (en) 2011-08-05 2024-01-09 Cardiovalve Ltd. Implant for heart valve
US11344410B2 (en) 2011-08-05 2022-05-31 Cardiovalve Ltd. Implant for heart valve
US11291545B2 (en) 2011-08-05 2022-04-05 Cardiovalve Ltd. Implant for heart valve
US11291547B2 (en) 2011-08-05 2022-04-05 Cardiovalve Ltd. Leaflet clip with collars
US11690712B2 (en) 2011-08-05 2023-07-04 Cardiovalve Ltd. Clip-secured implant for heart valve
US10702385B2 (en) 2011-08-05 2020-07-07 Cardiovalve Ltd. Implant for heart valve
US11369469B2 (en) 2011-08-05 2022-06-28 Cardiovalve Ltd. Method for use at a heart valve
US9358108B2 (en) 2011-09-12 2016-06-07 Highlife Sas Transcatheter valve prosthesis
US9662206B2 (en) 2011-09-12 2017-05-30 Highlife Sas Transcatheter valve prosthesis
US10828157B2 (en) 2011-09-12 2020-11-10 Highlife Sas Transcatheter valve prosthesis
US11642220B2 (en) 2011-09-12 2023-05-09 Highlife Sas Transcatheter valve prosthesis
US11617648B2 (en) 2011-10-19 2023-04-04 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US10945835B2 (en) 2011-10-19 2021-03-16 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US11202704B2 (en) 2011-10-19 2021-12-21 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9295552B2 (en) 2011-10-19 2016-03-29 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
JP7387819B2 (en) 2011-10-19 2023-11-28 トゥエルヴ, インコーポレイテッド artificial heart valve device
US10016271B2 (en) 2011-10-19 2018-07-10 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US10702380B2 (en) 2011-10-19 2020-07-07 Twelve, Inc. Devices, systems and methods for heart valve replacement
CN107028685A (en) * 2011-10-19 2017-08-11 托尔福公司 Artificial heart valve film device, artificial mitral valve and related systems and methods
US9034033B2 (en) 2011-10-19 2015-05-19 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9901443B2 (en) 2011-10-19 2018-02-27 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US20200390544A1 (en) * 2011-10-19 2020-12-17 Twelve, Inc. Devices, systems and methods for heart valve replacement
US11826249B2 (en) * 2011-10-19 2023-11-28 Twelve, Inc. Devices, systems and methods for heart valve replacement
US11497603B2 (en) 2011-10-19 2022-11-15 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
AU2016200392B2 (en) * 2011-10-19 2017-12-14 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US11628063B2 (en) 2011-10-19 2023-04-18 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
JP7097922B2 (en) 2011-10-19 2022-07-08 トゥエルヴ, インコーポレイテッド Artificial heart valve device
CN103889369A (en) * 2011-10-19 2014-06-25 托尔福公司 Devices, systems and methods for heart valve replacement
US10052204B2 (en) 2011-10-19 2018-08-21 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
AU2012325809B2 (en) * 2011-10-19 2016-01-21 Twelve, Inc. Devices, systems and methods for heart valve replacement
US9034032B2 (en) 2011-10-19 2015-05-19 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9763780B2 (en) 2011-10-19 2017-09-19 Twelve, Inc. Devices, systems and methods for heart valve replacement
US11197758B2 (en) 2011-10-19 2021-12-14 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
JP2020075161A (en) * 2011-10-19 2020-05-21 トゥエルヴ, インコーポレイテッド Prosthetic heart valve devices
EP2750630B1 (en) 2011-10-19 2021-06-30 Twelve, Inc. Device for heart valve replacement
AU2018201362B2 (en) * 2011-10-19 2019-05-16 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US10335278B2 (en) 2011-10-19 2019-07-02 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
AU2018201360B2 (en) * 2011-10-19 2019-05-16 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
WO2013059743A1 (en) * 2011-10-19 2013-04-25 Foundry Newco Xii, Inc. Devices, systems and methods for heart valve replacement
US9039757B2 (en) 2011-10-19 2015-05-26 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US10299927B2 (en) 2011-10-19 2019-05-28 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9655722B2 (en) 2011-10-19 2017-05-23 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US10299917B2 (en) 2011-10-19 2019-05-28 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US11413139B2 (en) 2011-11-23 2022-08-16 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US10537422B2 (en) 2011-11-23 2020-01-21 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US11364114B2 (en) 2011-12-21 2022-06-21 The Trustees Of The University Of Pennsylvania Platforms for mitral valve replacement
US10321988B2 (en) 2011-12-21 2019-06-18 The Trustees Of The University Of Pennsylvania Platforms for mitral valve replacement
EP3581152A1 (en) * 2011-12-21 2019-12-18 The Trustees of The University of Pennsylvania Platforms for mitral valve replacement
EP2793751A4 (en) * 2011-12-21 2016-01-13 Univ Pennsylvania Platforms for mitral valve replacement
US10238489B2 (en) 2011-12-21 2019-03-26 Edwards Lifesciences Corporation Anchoring device and method for replacing or repairing a heart valve
US11452602B2 (en) 2011-12-21 2022-09-27 Edwards Lifesciences Corporation Anchoring device for replacing or repairing a native heart valve annulus
US10849752B2 (en) 2011-12-21 2020-12-01 Edwards Lifesciences Corporation Methods for anchoring a device at a native heart valve annulus
US11376124B2 (en) 2012-01-31 2022-07-05 Mitral Valve Technologies Sarl Valve docking devices, systems and methods
US10226339B2 (en) 2012-01-31 2019-03-12 Mitral Valve Technologies Sarl Mitral valve docking devices, systems and methods
US11166812B2 (en) 2012-01-31 2021-11-09 Mitral Valve Technologies Sari Valve docking devices, systems and methods
US10363133B2 (en) 2012-02-14 2019-07-30 Neovac Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US11497602B2 (en) 2012-02-14 2022-11-15 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US11129714B2 (en) 2012-03-01 2021-09-28 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
US10258468B2 (en) 2012-03-01 2019-04-16 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
US9579198B2 (en) 2012-03-01 2017-02-28 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
US20150150678A1 (en) * 2012-03-22 2015-06-04 Stephen Brecker Replacement heart valve
EP2641570A1 (en) * 2012-03-22 2013-09-25 Brecker, Stephen Replacement heart valve
US9895225B2 (en) 2012-03-23 2018-02-20 Sorin Group Italia S.R.L. Collapsible valve prosthesis
US9427315B2 (en) 2012-04-19 2016-08-30 Caisson Interventional, LLC Valve replacement systems and methods
US10285810B2 (en) * 2012-04-19 2019-05-14 Caisson Interventional, LLC Valve replacement systems and methods
US20160331526A1 (en) * 2012-04-19 2016-11-17 Caisson Interventional, LLC Valve replacement systems and methods
US9566152B2 (en) 2012-04-19 2017-02-14 Caisson Interventional, LLC Heart valve assembly and methods
WO2013158608A1 (en) * 2012-04-19 2013-10-24 Caisson Interventional, LLC Heart valve assembly systems and methods
US10080656B2 (en) 2012-04-19 2018-09-25 Caisson Interventional Llc Heart valve assembly systems and methods
US11051935B2 (en) 2012-04-19 2021-07-06 Caisson Interventional, LLC Valve replacement systems and methods
US9011515B2 (en) 2012-04-19 2015-04-21 Caisson Interventional, LLC Heart valve assembly systems and methods
AU2013249485B2 (en) * 2012-04-19 2016-12-08 Caisson Interventional, LLC Heart valve assembly systems and methods
US10660750B2 (en) 2012-04-19 2020-05-26 Caisson Interventional, LLC Heart valve assembly systems and methods
EP2838476A4 (en) * 2012-04-19 2016-01-20 Caisson Interventional Llc Heart valve assembly systems and methods
US9427316B2 (en) * 2012-04-19 2016-08-30 Caisson Interventional, LLC Valve replacement systems and methods
US20140236291A1 (en) * 2012-04-19 2014-08-21 Caisson Interventional Llc Valve replacement systems and methods
US10314705B2 (en) 2012-05-30 2019-06-11 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US11617650B2 (en) 2012-05-30 2023-04-04 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US11389294B2 (en) 2012-05-30 2022-07-19 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US10940001B2 (en) 2012-05-30 2021-03-09 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US10016275B2 (en) 2012-05-30 2018-07-10 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
EP2861186B1 (en) 2012-06-19 2019-07-24 Boston Scientific Scimed, Inc. Replacement heart valve
US11759318B2 (en) * 2012-07-28 2023-09-19 Tendyne Holdings, Inc. Multi-component designs for heart valve retrieval device, sealing structures and stent assembly
US20180193138A1 (en) * 2012-07-28 2018-07-12 Tendyne Holdings, Inc. Multi-component designs for heart valve retrieval device, sealing structures and stent assembly
US20140046434A1 (en) * 2012-08-10 2014-02-13 Sorin Group Italia S.R.L. Valve prosthesis and kit
US9186249B2 (en) * 2012-08-10 2015-11-17 Sorin Group Italia S.R.L. Valve prosthesis and kit
AU2013299398B2 (en) * 2012-08-10 2017-09-28 Abiomed, Inc. Graft anchor devices, systems and methods
AU2013299398B9 (en) * 2012-08-10 2017-10-26 Abiomed, Inc. Graft anchor devices, systems and methods
EP2695586A1 (en) * 2012-08-10 2014-02-12 Sorin Group Italia S.r.l. A valve prosthesis and kit
US11213412B2 (en) 2012-08-10 2022-01-04 Abiomed, Inc. Graft anchor devices, systems and methods
US10463508B2 (en) 2012-08-10 2019-11-05 Abiomed, Inc. Graft anchor devices, systems and methods
US10143571B2 (en) * 2012-08-10 2018-12-04 Abiomed, Inc. Graft anchor devices, systems and methods
US20150216685A1 (en) * 2012-08-10 2015-08-06 Abiomed, Inc. Graft anchor devices, systems and methods
US20220054266A1 (en) * 2012-08-13 2022-02-24 Medtronic, Inc. Heart valve prosthesis
US10835377B2 (en) 2013-01-24 2020-11-17 Cardiovalve Ltd. Rolled prosthetic valve support
US11135059B2 (en) 2013-01-24 2021-10-05 Cardiovalve Ltd. Prosthetic valve and upstream support therefor
US10631982B2 (en) 2013-01-24 2020-04-28 Cardiovale Ltd. Prosthetic valve and upstream support therefor
US11844691B2 (en) 2013-01-24 2023-12-19 Cardiovalve Ltd. Partially-covered prosthetic valves
US20140243954A1 (en) * 2013-02-27 2014-08-28 Donald Shannon Transcatheter mitral valve prosthesis
US10583002B2 (en) 2013-03-11 2020-03-10 Neovasc Tiara Inc. Prosthetic valve with anti-pivoting mechanism
US9730791B2 (en) 2013-03-14 2017-08-15 Edwards Lifesciences Cardiaq Llc Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US9681951B2 (en) 2013-03-14 2017-06-20 Edwards Lifesciences Cardiaq Llc Prosthesis with outer skirt and anchors
JP7034116B2 (en) 2013-03-15 2022-03-11 トゥエルヴ, インコーポレイテッド Artificial heart valve devices, artificial mitral valves, and related systems and methods
JP2019141714A (en) * 2013-03-15 2019-08-29 トゥエルヴ, インコーポレイテッド Prosthetic heart valve device, prosthetic mitral valve and associated system and method
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
US10383728B2 (en) 2013-04-04 2019-08-20 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
US11389291B2 (en) 2013-04-04 2022-07-19 Neovase Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
US11234821B2 (en) 2013-05-20 2022-02-01 Twelve, Inc. Implantable heart valve devices, mitral valve repair devices and associated systems and methods
US10111747B2 (en) 2013-05-20 2018-10-30 Twelve, Inc. Implantable heart valve devices, mitral valve repair devices and associated systems and methods
US20140371844A1 (en) * 2013-06-18 2014-12-18 St. Jude Medical, Cardiology Division, Inc. Transcatheter mitral valve and delivery system
EP3010446B1 (en) 2013-06-19 2018-12-19 AGA Medical Corporation Collapsible valve having paravalvular leak protection
US10154906B2 (en) 2013-07-17 2018-12-18 Cephea Valve Technologies, Inc. System and method for cardiac valve repair and replacement
US9554899B2 (en) 2013-07-17 2017-01-31 Cephea Valve Technologies, Inc. System and method for cardiac valve repair and replacement
US9561103B2 (en) 2013-07-17 2017-02-07 Cephea Valve Technologies, Inc. System and method for cardiac valve repair and replacement
US20170354499A1 (en) * 2013-07-17 2017-12-14 Juan F. Granada System and method for cardiac valve repair and replacement
US10624742B2 (en) 2013-07-17 2020-04-21 Cephea Valve Technologies, Inc. System and method for cardiac valve repair and replacement
WO2015009503A3 (en) * 2013-07-17 2015-03-19 Cephea Valve Technologies, Inc. System and method for cardiac valve repair and replacement
US11510780B2 (en) 2013-07-17 2022-11-29 Cephea Valve Technologies, Inc. System and method for cardiac valve repair and replacement
US10149761B2 (en) * 2013-07-17 2018-12-11 Cephea Valve Technlologies, Inc. System and method for cardiac valve repair and replacement
US9724083B2 (en) 2013-07-26 2017-08-08 Edwards Lifesciences Cardiaq Llc Systems and methods for sealing openings in an anatomical wall
US10143550B2 (en) 2013-08-08 2018-12-04 Sorin Group Italia S.R.L. Heart valve prosthesis
US20160199177A1 (en) * 2013-08-12 2016-07-14 Landon H. Tompkins Apparatus and methods for implanting a replacement heart valve
US10034749B2 (en) * 2013-08-12 2018-07-31 Mitral Valve Technologies Sarl Apparatus and methods for implanting a replacement heart valve
CN107744416A (en) * 2013-08-12 2018-03-02 米特拉尔维尔福科技有限责任公司 For being implanted into the apparatus and method of replacement heart valve
US11793630B2 (en) 2013-08-12 2023-10-24 Mitral Valve Technologies Sarl Apparatus and methods for implanting a replacement heart valve
US10945837B2 (en) 2013-08-12 2021-03-16 Mitral Valve Technologies Sarl Apparatus and methods for implanting a replacement heart valve
US11229515B2 (en) 2013-08-14 2022-01-25 Mitral Valve Technologies Sarl Replacement heart valve systems and methods
US11234811B2 (en) 2013-08-14 2022-02-01 Mitral Valve Technologies Sarl Replacement heart valve systems and methods
US10052198B2 (en) 2013-08-14 2018-08-21 Mitral Valve Technologies Sarl Coiled anchor for supporting prosthetic heart valve, prosthetic heart valve, and deployment device
US10226330B2 (en) 2013-08-14 2019-03-12 Mitral Valve Technologies Sarl Replacement heart valve apparatus and methods
US11304797B2 (en) 2013-08-14 2022-04-19 Mitral Valve Technologies Sarl Replacement heart valve methods
US11523899B2 (en) 2013-08-14 2022-12-13 Mitral Valve Technologies Sarl Coiled anchor for supporting prosthetic heart valve, prosthetic heart valve, and deployment device
US10588742B2 (en) 2013-08-14 2020-03-17 Mitral Valve Technologies Sarl Coiled anchor for supporting prosthetic heart valve, prosthetic heart valve, and deployment device
US11103347B2 (en) 2013-09-10 2021-08-31 Edwards Lifesciences Corporation Magnetic retaining mechanisms for prosthetic valves
US10195028B2 (en) 2013-09-10 2019-02-05 Edwards Lifesciences Corporation Magnetic retaining mechanisms for prosthetic valves
US11690716B2 (en) 2013-09-10 2023-07-04 Edwards Lifesciences Corporation Method for delivering a support member to a native heart valve
US11833035B2 (en) 2013-10-23 2023-12-05 Caisson Interventional Llc Methods and systems for heart valve therapy
US9421094B2 (en) * 2013-10-23 2016-08-23 Caisson Interventional, LLC Methods and systems for heart valve therapy
US10117741B2 (en) 2013-10-23 2018-11-06 Caisson Interventional, LLC Methods and systems for heart valve therapy
US9050188B2 (en) 2013-10-23 2015-06-09 Caisson Interventional, LLC Methods and systems for heart valve therapy
AU2014340151B2 (en) * 2013-10-23 2018-03-15 Caisson Interventional, LLC Methods and systems for heart valve therapy
US20150112433A1 (en) * 2013-10-23 2015-04-23 Caisson Interventional Llc Methods and systems for heart valve therapy
US10736736B2 (en) 2013-10-23 2020-08-11 Caisson Interventional, LLC Methods and systems for heart valve therapy
US10646333B2 (en) 2013-10-24 2020-05-12 Medtronic, Inc. Two-piece valve prosthesis with anchor stent and valve component
US11628061B2 (en) 2013-10-24 2023-04-18 Medtronic, Inc. Modular valve prosthesis with anchor stent and valve component
US11497606B2 (en) 2013-10-25 2022-11-15 Polares Medical Inc. Systems and methods for transcatheter treatment of valve regurgitation
US10166098B2 (en) 2013-10-25 2019-01-01 Middle Peak Medical, Inc. Systems and methods for transcatheter treatment of valve regurgitation
US11000372B2 (en) 2013-10-25 2021-05-11 Polares Medical Inc. Systems and methods for transcatheter treatment of valve regurgitation
US11337810B2 (en) 2013-11-22 2022-05-24 Edwards Lifesciences Corporation Valvular insufficiency repair device and method
US11589988B2 (en) 2013-11-22 2023-02-28 Edwards Lifesciences Corporation Valvular insufficiency repair device and method
CN109674560A (en) * 2014-02-21 2019-04-26 米特拉尔维尔福科技有限责任公司 For delivering the devices, systems, and methods of artificial mitral valve and anchor
US10898320B2 (en) * 2014-02-21 2021-01-26 Mitral Valve Technologies Sarl Devices, systems and methods for delivering a prosthetic mitral valve and anchoring device
US10052199B2 (en) * 2014-02-21 2018-08-21 Mitral Valve Technologies Sarl Devices, systems and methods for delivering a prosthetic mitral valve and anchoring device
US20150238313A1 (en) * 2014-02-21 2015-08-27 Mitral Valve Technologies, Sarl Devices, systems and methods for delivering a prosthetic mitral valve and anchoring device
USD755384S1 (en) 2014-03-05 2016-05-03 Edwards Lifesciences Cardiaq Llc Stent
US10064719B2 (en) * 2014-03-11 2018-09-04 Highlife Sas Transcatheter valve prosthesis
US20150257880A1 (en) * 2014-03-11 2015-09-17 Highlife Sas Transcatheter valve prosthesis
US9889003B2 (en) * 2014-03-11 2018-02-13 Highlife Sas Transcatheter valve prosthesis
US20150257882A1 (en) * 2014-03-11 2015-09-17 Highlife Sas Transcatheter valve prosthesis
CN106102659A (en) * 2014-03-14 2016-11-09 安东尼欧·法兰西斯寇·纳维斯·费侯 There is support and the support bringing device of mechanicalness or biological heart valve for Wicresoft's valve replacement surgery
EP3117802A4 (en) * 2014-03-14 2017-12-06 Neves Filho, Antonio Francisco Stent with mechanical or biological heart valve for minimally invasive valve replacement procedure, and applicator
US20170056165A1 (en) * 2014-03-14 2017-03-02 Antonio Francisco Neves Filho Stent With Mechanical Or Biological Heart Valve For Minimally Invasive Valve Replacement Procedure And Stent Application Device
CN106456321A (en) * 2014-05-14 2017-02-22 索林集团意大利有限责任公司 Implant device and implantation kit
USRE49792E1 (en) 2014-05-14 2024-01-09 Corcym S.R.L. Implant device and implantation kit
US10245141B2 (en) 2014-05-14 2019-04-02 Sorin Group Italia S.R.L. Implant device and implantation kit
WO2015173609A1 (en) 2014-05-14 2015-11-19 Sorin Group Italia S.R.L. Implant device and implantation kit
US10835375B2 (en) 2014-06-12 2020-11-17 Caisson Interventional, LLC Two stage anchor and mitral valve assembly
US9974647B2 (en) 2014-06-12 2018-05-22 Caisson Interventional, LLC Two stage anchor and mitral valve assembly
US10500048B2 (en) 2014-06-18 2019-12-10 Polares Medical Inc. Mitral valve implants for the treatment of valvular regurgitation
US11622759B2 (en) 2014-06-24 2023-04-11 Polares Medical Inc. Systems and methods for anchoring an implant
US10251635B2 (en) 2014-06-24 2019-04-09 Middle Peak Medical, Inc. Systems and methods for anchoring an implant
US11872130B2 (en) 2014-07-30 2024-01-16 Cardiovalve Ltd. Prosthetic heart valve implant
US10524910B2 (en) 2014-07-30 2020-01-07 Mitraltech Ltd. 3 Ariel Sharon Avenue Articulatable prosthetic valve
US11701225B2 (en) 2014-07-30 2023-07-18 Cardiovalve Ltd. Delivery of a prosthetic valve
US10492908B2 (en) 2014-07-30 2019-12-03 Cardiovalve Ltd. Anchoring of a prosthetic valve
EP2982336A1 (en) 2014-08-04 2016-02-10 Alvimedica Tibb Ürünler San. Ve Dis Tic. A.S. Mitral valve prosthesis, particularly suitable for transcatheter implantation
CN106714734A (en) * 2014-08-21 2017-05-24 爱德华兹生命科学公司 Dual-flange prosthetic valve frame
CN112220505A (en) * 2014-09-09 2021-01-15 奥特鲁泰克控股有限公司 Flow regulating device in heart
US11406493B2 (en) 2014-09-12 2022-08-09 Mitral Valve Technologies Sarl Mitral repair and replacement devices and methods
US10016272B2 (en) 2014-09-12 2018-07-10 Mitral Valve Technologies Sarl Mitral repair and replacement devices and methods
US10653519B2 (en) 2014-09-12 2020-05-19 Mitral Valve Technologies Sarl Mitral repair and replacement devices and methods
US9750605B2 (en) 2014-10-23 2017-09-05 Caisson Interventional, LLC Systems and methods for heart valve therapy
US10603167B2 (en) 2014-10-23 2020-03-31 Caisson Interventional, LLC Systems and methods for heart valve therapy
US11439506B2 (en) 2014-10-23 2022-09-13 Caisson Interventional Llc Systems and methods for heart valve therapy
US9750607B2 (en) 2014-10-23 2017-09-05 Caisson Interventional, LLC Systems and methods for heart valve therapy
US9750606B2 (en) 2014-10-23 2017-09-05 Caisson Interventional, LLC Systems and methods for heart valve therapy
CN106999281A (en) * 2014-11-26 2017-08-01 康斯坦丁诺斯·斯帕尔吉亚斯 Through conduit cardiac-valve prosthesis and delivery system
WO2016083551A1 (en) * 2014-11-26 2016-06-02 Konstantinos Spargias Transcatheter prosthetic heart valve and delivery system
US10531951B2 (en) 2014-11-26 2020-01-14 Edwards Lifesciences Corporation Transcatheter prosthetic heart valve and delivery system
US11559395B2 (en) 2014-11-26 2023-01-24 Edwards Lifesciences Corporation Transcatheter prosthetic heart valve and delivery system
US10869755B2 (en) * 2014-12-09 2020-12-22 Cephea Valve Technologies, Inc. Replacement cardiac valves and methods of use and manufacture
US11147665B2 (en) 2014-12-09 2021-10-19 Cepha Valve Technologies, Inc. Replacement cardiac valves and methods of use and manufacture
US20160158003A1 (en) * 2014-12-09 2016-06-09 Dan Wallace Replacement cardiac valves and methods of use and manufacture
US20160158000A1 (en) * 2014-12-09 2016-06-09 Juan F. Granada Replacement cardiac valves and methods of use and manufacture
US9439757B2 (en) 2014-12-09 2016-09-13 Cephea Valve Technologies, Inc. Replacement cardiac valves and methods of use and manufacture
US9492273B2 (en) 2014-12-09 2016-11-15 Cephea Valve Technologies, Inc. Replacement cardiac valves and methods of use and manufacture
US10433953B2 (en) 2014-12-09 2019-10-08 Cephea Valve Technologies, Inc. Replacement cardiac valves and methods of use and manufacture
US10548721B2 (en) * 2014-12-09 2020-02-04 Cephea Valve Technologies, Inc. Replacement cardiac valves and methods of use and manufacture
US10507105B2 (en) 2015-02-05 2019-12-17 Cardiovalve Ltd. Prosthetic valve with tissue anchors free from lateral interconnections
US10357360B2 (en) 2015-02-05 2019-07-23 Cardiovalve Ltd. Prosthetic valve with aligned inner and outer frames
US10426610B2 (en) * 2015-02-05 2019-10-01 Cardiovalve Ltd. Prosthetic valve with radially-deflectable tissue anchors
US10973636B2 (en) 2015-02-05 2021-04-13 Cardiovalve Ltd. Prosthetic valve with tissue anchors free from lateral interconnections
US11801135B2 (en) 2015-02-05 2023-10-31 Cardiovalve Ltd. Techniques for deployment of a prosthetic valve
US10449047B2 (en) 2015-02-05 2019-10-22 Cardiovalve Ltd. Prosthetic heart valve with compressible frames
US10463487B2 (en) 2015-02-05 2019-11-05 Cardiovalve Ltd. Prosthetic valve delivery system with independently-movable capsule portions
US10463488B2 (en) 2015-02-05 2019-11-05 Cardiovalve Ltd. Prosthetic valve with separably-deployable valve body and tissue anchors
US20180271654A1 (en) * 2015-02-05 2018-09-27 Mitraltech Ltd. Prosthetic Valve with Axially-Sliding Frames
US10918481B2 (en) 2015-02-05 2021-02-16 Cardiovalve Ltd. Techniques for deployment of a prosthetic valve
US10390952B2 (en) * 2015-02-05 2019-08-27 Cardiovalve Ltd. Prosthetic valve with flexible tissue anchor portions
US10524903B2 (en) 2015-02-05 2020-01-07 Cardiovalve Ltd. Prosthetic valve with aligned inner and outer frames
US10758344B2 (en) 2015-02-05 2020-09-01 Cardiovalve Ltd. Prosthetic valve with angularly offset frames
US11672658B2 (en) 2015-02-05 2023-06-13 Cardiovalve Ltd. Prosthetic valve with aligned inner and outer frames
US10736742B2 (en) 2015-02-05 2020-08-11 Cardiovalve Ltd. Prosthetic valve with atrial arms
US10888422B2 (en) 2015-02-05 2021-01-12 Cardiovalve Ltd. Prosthetic valve with flexible tissue anchor portions
US10722360B2 (en) 2015-02-05 2020-07-28 Cardiovalve Ltd. Prosthetic valve with radially-deflectable tissue anchors
US11793638B2 (en) * 2015-02-05 2023-10-24 Cardiovalve Ltd. Prosthetic valve with pivoting tissue anchor portions
US10864078B2 (en) 2015-02-05 2020-12-15 Cardiovalve Ltd. Prosthetic valve with separably-deployable valve body and tissue anchors
US20200297486A1 (en) * 2015-02-05 2020-09-24 Cardiovalve Ltd. Prosthetic valve with pivoting tissue anchor portions
US11534298B2 (en) 2015-02-05 2022-12-27 Cardiovalve Ltd. Prosthetic valve with s-shaped tissue anchors
US10667908B2 (en) 2015-02-05 2020-06-02 Cardiovalve Ltd. Prosthetic valve with S-shaped tissue anchors
US10682227B2 (en) 2015-02-05 2020-06-16 Cardiovalve Ltd. Prosthetic valve with pivoting tissue anchor portions
US10849748B2 (en) 2015-02-05 2020-12-01 Cardiovalve Ltd. Prosthetic valve delivery system with independently-movable capsule portions
US10695177B2 (en) 2015-02-05 2020-06-30 Cardiovalve Ltd. Prosthetic valve with aligned inner and outer frames
US11793635B2 (en) 2015-02-05 2023-10-24 Cardiovalve Ltd. Prosthetic valve with angularly offset frames
US10231834B2 (en) 2015-02-09 2019-03-19 Edwards Lifesciences Corporation Low profile transseptal catheter and implant system for minimally invasive valve procedure
US11033386B2 (en) 2015-02-09 2021-06-15 Edwards Lifesciences Corporation Low profile transseptal catheter and implant system for minimally invasive valve procedure
US11786364B2 (en) 2015-02-11 2023-10-17 Edwards Lifesciences Corporation Delivery apparatuses for medical device implants
US10039637B2 (en) 2015-02-11 2018-08-07 Edwards Lifesciences Corporation Heart valve docking devices and implanting methods
US10758341B2 (en) 2015-02-11 2020-09-01 Edwards Lifesciences Corporation Heart valve docking devices and implanting methods
US11737869B2 (en) 2015-02-12 2023-08-29 Medtronic, Inc. Integrated valve assembly and method of delivering and deploying an integrated valve assembly
US10799343B2 (en) 2015-02-12 2020-10-13 Medtronic, Inc. Integrated valve assembly and method of delivering and deploying an integrated valve assembly
US11497600B2 (en) 2015-03-19 2022-11-15 Caisson Interventional, LLC Systems and methods for heart valve therapy
US10449039B2 (en) 2015-03-19 2019-10-22 Caisson Interventional, LLC Systems and methods for heart valve therapy
US11369470B2 (en) 2015-03-20 2022-06-28 St. Jude Medical, Cardiology Division, Inc. Mitral valve loading tool
US10531954B2 (en) 2015-03-20 2020-01-14 St. Jude Medical, Cardiology Division, Inc. Mitral valve loading tool
US10143552B2 (en) 2015-05-14 2018-12-04 Cephea Valve Technologies, Inc. Replacement mitral valves
US10849746B2 (en) 2015-05-14 2020-12-01 Cephea Valve Technologies, Inc. Cardiac valve delivery devices and systems
US11786373B2 (en) 2015-05-14 2023-10-17 Cephea Valve Technologies, Inc. Cardiac valve delivery devices and systems
US10555808B2 (en) 2015-05-14 2020-02-11 Cephea Valve Technologies, Inc. Replacement mitral valves
US10470881B2 (en) 2015-05-14 2019-11-12 Cephea Valve Technologies, Inc. Replacement mitral valves
US11617646B2 (en) 2015-05-14 2023-04-04 Cephea Valve Technologies, Inc. Replacement mitral valves
US20190110894A1 (en) * 2015-06-12 2019-04-18 St. Jude Medical, Cardiology Division, Inc. Heart Valve Repair and Replacement
US10856974B2 (en) * 2015-06-12 2020-12-08 St. Jude Medical, Cardiology Division, Inc. Heart valve repair and replacement
US10820996B2 (en) 2015-08-21 2020-11-03 Twelve, Inc. Implantable heart valve devices, mitral valve repair devices and associated systems and methods
US11576782B2 (en) 2015-08-21 2023-02-14 Twelve, Inc. Implantable heart valve devices, mitral valve repair devices and associated systems and methods
US10238490B2 (en) 2015-08-21 2019-03-26 Twelve, Inc. Implant heart valve devices, mitral valve repair devices and associated systems and methods
US10034747B2 (en) 2015-08-27 2018-07-31 Medtronic Vascular, Inc. Prosthetic valve system having a docking component and a prosthetic valve component
US11413172B2 (en) 2015-09-01 2022-08-16 Medtronic, Inc. Stent assemblies including passages to provide blood flow to coronary arteries and methods of delivering and deploying such stent assemblies
US9592121B1 (en) 2015-11-06 2017-03-14 Middle Peak Medical, Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
US11160656B2 (en) 2015-11-06 2021-11-02 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
US10376365B2 (en) 2015-11-06 2019-08-13 Middle Peak Medical, Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
WO2017083413A1 (en) 2015-11-10 2017-05-18 Edwards Lifesciences Corporation Transcatheter heart valve for replacing natural mitral valve
CN108366858A (en) * 2015-11-10 2018-08-03 爱德华兹生命科学公司 It is natural mitral through catheter heart valves for replacing
US10470876B2 (en) 2015-11-10 2019-11-12 Edwards Lifesciences Corporation Transcatheter heart valve for replacing natural mitral valve
EP3380042B1 (en) 2015-11-23 2019-12-11 TricPer SAS Assembly for replacing the tricuspid atrioventricular valve
US11154396B2 (en) 2015-11-23 2021-10-26 T-Heart SAS Assembly for replacing the tricuspid atrioventricular valve
US10939998B2 (en) 2015-12-30 2021-03-09 Caisson Interventional, LLC Systems and methods for heart valve therapy
US10265166B2 (en) 2015-12-30 2019-04-23 Caisson Interventional, LLC Systems and methods for heart valve therapy
US11833034B2 (en) * 2016-01-13 2023-12-05 Shifamed Holdings, Llc Prosthetic cardiac valve devices, systems, and methods
US11819403B2 (en) 2016-02-05 2023-11-21 Edwards Lifesciences Corporation Devices and systems for docking a heart valve
US11191638B2 (en) 2016-02-05 2021-12-07 Edwards Lifesciences Corporation Devices and systems for docking a heart valve
US11717398B2 (en) 2016-02-05 2023-08-08 Edwards Lifesciences Corporation Methods for docking a heart valve
US11596514B2 (en) 2016-02-05 2023-03-07 Edwards Lifesciences Corporation Devices and systems for docking a heart valve
US11717399B2 (en) 2016-02-05 2023-08-08 Edwards Lifesciences Corporation Devices and systems for docking a heart valve
US10363130B2 (en) 2016-02-05 2019-07-30 Edwards Lifesciences Corporation Devices and systems for docking a heart valve
US11298117B2 (en) 2016-02-16 2022-04-12 Cardiovalve Ltd. Techniques for providing a replacement valve and transseptal communication
US10531866B2 (en) 2016-02-16 2020-01-14 Cardiovalve Ltd. Techniques for providing a replacement valve and transseptal communication
US11000370B2 (en) 2016-03-02 2021-05-11 Peca Labs, Inc. Expandable implantable conduit
US11033390B2 (en) 2016-04-29 2021-06-15 Medtronic Vascular, Inc. Prosthetic heart valve devices with tethered anchors and associated systems and methods
US10265172B2 (en) 2016-04-29 2019-04-23 Medtronic Vascular, Inc. Prosthetic heart valve devices with tethered anchors and associated systems and methods
US11337806B2 (en) 2016-05-13 2022-05-24 St. Jude Medical, Cardiology Division, Inc. Mitral valve delivery device
US10624740B2 (en) 2016-05-13 2020-04-21 St. Jude Medical, Cardiology Division, Inc. Mitral valve delivery device
US11331187B2 (en) 2016-06-17 2022-05-17 Cephea Valve Technologies, Inc. Cardiac valve delivery devices and systems
US10588745B2 (en) 2016-06-20 2020-03-17 Medtronic Vascular, Inc. Modular valve prosthesis, delivery system, and method of delivering and deploying a modular valve prosthesis
US11786371B2 (en) 2016-06-20 2023-10-17 Medtronic Vascular, Inc. Modular valve prosthesis, delivery system, and method of delivering and deploying a modular valve prosthesis
US10828150B2 (en) 2016-07-08 2020-11-10 Edwards Lifesciences Corporation Docking station for heart valve prosthesis
US10952850B2 (en) 2016-08-01 2021-03-23 Cardiovalve Ltd. Minimally-invasive delivery systems
US10426614B2 (en) 2016-08-01 2019-10-01 Cardiovalve Ltd. Minimally-invasive delivery systems
US10856975B2 (en) 2016-08-10 2020-12-08 Cardiovalve Ltd. Prosthetic valve with concentric frames
US11779458B2 (en) 2016-08-10 2023-10-10 Cardiovalve Ltd. Prosthetic valve with leaflet connectors
US11801133B2 (en) 2016-08-26 2023-10-31 Edwards Lifesciences Corporation Heart valve docking devices and systems
US11344407B2 (en) 2016-08-26 2022-05-31 Edwards Lifesciences Corporation Heart valve docking coils and systems
US10722359B2 (en) 2016-08-26 2020-07-28 Edwards Lifesciences Corporation Heart valve docking devices and systems
US10463479B2 (en) 2016-08-26 2019-11-05 Edwards Lifesciences Corporation Heart valve docking coils and systems
US10687938B2 (en) 2016-08-26 2020-06-23 Edwards Lifesciences Corporation Heart valve docking system
US11690708B2 (en) 2016-08-26 2023-07-04 Edwards Lifesciences Corporation Heart valve docking system
US10357361B2 (en) 2016-09-15 2019-07-23 Edwards Lifesciences Corporation Heart valve pinch devices and delivery systems
US11844692B2 (en) 2016-09-15 2023-12-19 Edwards Lifesciences Corporation Heart valve pinch devices and delivery systems
US11253361B2 (en) 2016-09-15 2022-02-22 Edwards Lifesciences Corporation Heart valve pinch devices and delivery systems
US10610357B2 (en) 2016-10-10 2020-04-07 Peca Labs, Inc. Transcatheter stent and valve assembly
US10631979B2 (en) 2016-10-10 2020-04-28 Peca Labs, Inc. Transcatheter stent and valve assembly
US10940000B2 (en) 2016-12-16 2021-03-09 Edwards Lifesciences Corporation Deployment systems, tools, and methods for delivering an anchoring device for a prosthetic valve
US11382744B2 (en) 2016-12-16 2022-07-12 Edwards Lifesciences Corporation Steerable delivery catheter
US11759317B2 (en) 2016-12-20 2023-09-19 Edwards Lifesciences Corporation Three-dimensional woven fabric implant devices
US11065111B2 (en) 2016-12-20 2021-07-20 Edwards Lifesciences Corporation Systems and mechanisms for deploying a docking device for a replacement heart valve
US11877925B2 (en) 2016-12-20 2024-01-23 Edwards Lifesciences Corporation Systems and mechanisms for deploying a docking device for a replacement heart valve
US10813749B2 (en) 2016-12-20 2020-10-27 Edwards Lifesciences Corporation Docking device made with 3D woven fabric
US10568737B2 (en) 2017-01-23 2020-02-25 Cephea Valve Technologies, Inc. Replacement mitral valves
US11633278B2 (en) 2017-01-23 2023-04-25 Cephea Valve Technologies, Inc. Replacement mitral valves
US10828153B2 (en) * 2017-01-23 2020-11-10 Cephea Valve Technologies, Inc. Replacement mitral valves
US11185406B2 (en) 2017-01-23 2021-11-30 Edwards Lifesciences Corporation Covered prosthetic heart valve
US11090158B2 (en) 2017-01-23 2021-08-17 Cephea Valve Technologies, Inc. Replacement mitral valves
US10368990B2 (en) 2017-01-23 2019-08-06 Cephea Valve Technologies, Inc. Replacement mitral valves
US20180206985A1 (en) * 2017-01-23 2018-07-26 Spencer NOE Replacement mitral valves
US11058535B2 (en) 2017-01-23 2021-07-13 Cephea Valve Technologies, Inc. Replacement mitral valves
US11013600B2 (en) 2017-01-23 2021-05-25 Edwards Lifesciences Corporation Covered prosthetic heart valve
US11654023B2 (en) 2017-01-23 2023-05-23 Edwards Lifesciences Corporation Covered prosthetic heart valve
USD977101S1 (en) 2017-02-01 2023-01-31 Edwards Lifesciences Corporation Stent
USD867595S1 (en) 2017-02-01 2019-11-19 Edwards Lifesciences Corporation Stent
US10653524B2 (en) 2017-03-13 2020-05-19 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
US11298229B2 (en) 2017-03-13 2022-04-12 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
US10702386B2 (en) 2017-03-13 2020-07-07 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
US11672659B2 (en) 2017-03-13 2023-06-13 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
US10123874B2 (en) 2017-03-13 2018-11-13 Middle Peak Medical, Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
US11534302B2 (en) 2017-03-13 2022-12-27 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
US10478303B2 (en) 2017-03-13 2019-11-19 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
US11654021B2 (en) 2017-04-18 2023-05-23 Twelve, Inc. Prosthetic heart valve device and associated systems and methods
US10433961B2 (en) 2017-04-18 2019-10-08 Twelve, Inc. Delivery systems with tethers for prosthetic heart valve devices and associated methods
US10702378B2 (en) 2017-04-18 2020-07-07 Twelve, Inc. Prosthetic heart valve device and associated systems and methods
US11737873B2 (en) 2017-04-18 2023-08-29 Twelve, Inc. Hydraulic systems for delivering prosthetic heart valve devices and associated methods
US11389295B2 (en) 2017-04-18 2022-07-19 Twelve, Inc. Delivery systems with tethers for prosthetic heart valve devices and associated methods
US10575950B2 (en) 2017-04-18 2020-03-03 Twelve, Inc. Hydraulic systems for delivering prosthetic heart valve devices and associated methods
US11786370B2 (en) 2017-05-11 2023-10-17 Twelve, Inc. Delivery systems for delivering prosthetic heart valve devices and associated methods
US10792151B2 (en) 2017-05-11 2020-10-06 Twelve, Inc. Delivery systems for delivering prosthetic heart valve devices and associated methods
US10842619B2 (en) 2017-05-12 2020-11-24 Edwards Lifesciences Corporation Prosthetic heart valve docking assembly
US11607310B2 (en) 2017-05-12 2023-03-21 Edwards Lifesciences Corporation Prosthetic heart valve docking assembly
US10646338B2 (en) 2017-06-02 2020-05-12 Twelve, Inc. Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods
US11559398B2 (en) 2017-06-02 2023-01-24 Twelve, Inc. Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods
US10709591B2 (en) 2017-06-06 2020-07-14 Twelve, Inc. Crimping device and method for loading stents and prosthetic heart valves
US11464659B2 (en) 2017-06-06 2022-10-11 Twelve, Inc. Crimping device for loading stents and prosthetic heart valves
US11291540B2 (en) 2017-06-30 2022-04-05 Edwards Lifesciences Corporation Docking stations for transcatheter valves
US11311399B2 (en) 2017-06-30 2022-04-26 Edwards Lifesciences Corporation Lock and release mechanisms for trans-catheter implantable devices
US10786352B2 (en) 2017-07-06 2020-09-29 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10729541B2 (en) 2017-07-06 2020-08-04 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US11877926B2 (en) 2017-07-06 2024-01-23 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10575948B2 (en) 2017-08-03 2020-03-03 Cardiovalve Ltd. Prosthetic heart valve
US10537426B2 (en) 2017-08-03 2020-01-21 Cardiovalve Ltd. Prosthetic heart valve
US11571298B2 (en) 2017-08-03 2023-02-07 Cardiovalve Ltd. Prosthetic valve with appendages
US11246704B2 (en) 2017-08-03 2022-02-15 Cardiovalve Ltd. Prosthetic heart valve
US11793633B2 (en) 2017-08-03 2023-10-24 Cardiovalve Ltd. Prosthetic heart valve
USD890333S1 (en) 2017-08-21 2020-07-14 Edwards Lifesciences Corporation Heart valve docking coil
US11395726B2 (en) 2017-09-11 2022-07-26 Incubar Llc Conduit vascular implant sealing device for reducing endoleaks
US11337802B2 (en) 2017-09-19 2022-05-24 Cardiovalve Ltd. Heart valve delivery systems and methods
US11318015B2 (en) 2017-09-19 2022-05-03 Cardiovalve Ltd. Prosthetic valve configured to fill a volume between tissue anchors with native valve tissue
US10905548B2 (en) * 2017-09-19 2021-02-02 Cardio Valve Ltd. Prosthetic valve with protective sleeve around an outlet rim
US10881511B2 (en) 2017-09-19 2021-01-05 Cardiovalve Ltd. Prosthetic valve with tissue anchors configured to exert opposing clamping forces on native valve tissue
US10856982B2 (en) 2017-09-19 2020-12-08 St. Jude Medical, Cardiology Division, Inc. Transapical mitral valve delivery system
US10905549B2 (en) 2017-09-19 2021-02-02 Cardiovalve Ltd. Prosthetic valve with overlapping atrial tissue anchors and ventricular tissue anchors
US10856972B2 (en) 2017-09-19 2020-12-08 Cardiovalve Ltd. Prosthetic valve with angularly offset atrial anchoring arms and ventricular anchoring legs
US20190083246A1 (en) * 2017-09-19 2019-03-21 Cardiovalve Ltd. Prosthetic valve with protective sleeve around an outlet rim
US10799345B2 (en) 2017-09-19 2020-10-13 Cardiovalve Ltd. Prosthetic valve with protective fabric covering around tissue anchor bases
US11819405B2 (en) 2017-09-19 2023-11-21 Cardiovalve Ltd. Prosthetic valve with inflatable cuff configured for radial extension
US11304804B2 (en) 2017-09-19 2022-04-19 Cardiovalve, Ltd. Prosthetic valve with connecting struts of variable size and tissue anchoring legs of variable size that extend from junctions
US11304805B2 (en) * 2017-09-19 2022-04-19 Cardiovalve Ltd. Prosthetic valve with inflatable cuff configured to fill a volume between atrial and ventricular tissue anchors
US11304806B2 (en) 2017-09-19 2022-04-19 Cardiovalve Ltd. Prosthetic valve with atrial tissue anchors having variable flexibility and ventricular tissue anchors having constant flexibility
US20190083249A1 (en) * 2017-09-19 2019-03-21 Cardiovalve Ltd. Prosthetic valve with inflatable cuff configured to fill a volume between atrial and ventricular tissue anchors
US11318014B2 (en) 2017-09-19 2022-05-03 Cardiovalve Ltd. Prosthetic valve delivery system with multi-planar steering
US10888421B2 (en) 2017-09-19 2021-01-12 Cardiovalve Ltd. Prosthetic heart valve with pouch
US11337803B2 (en) 2017-09-19 2022-05-24 Cardiovalve Ltd. Prosthetic valve with inner and outer frames connected at a location of tissue anchor portion
US11337804B2 (en) 2017-09-19 2022-05-24 Cardiovalve Ltd. Prosthetic valve with radially-deformable tissue anchors configured to restrict axial valve migration
US11864996B2 (en) 2017-09-19 2024-01-09 Cardiovalve Ltd. Prosthetic valve with protective sleeve around an outlet rim
US11648122B2 (en) 2017-10-19 2023-05-16 Cardiovalve Ltd. Techniques for use with prosthetic valve leaflets
US11872131B2 (en) 2017-12-13 2024-01-16 Cardiovalve Ltd. Prosthetic valve and delivery tool therefor
US11382746B2 (en) 2017-12-13 2022-07-12 Cardiovalve Ltd. Prosthetic valve and delivery tool therefor
US11633277B2 (en) 2018-01-10 2023-04-25 Cardiovalve Ltd. Temperature-control during crimping of an implant
US11872124B2 (en) 2018-01-10 2024-01-16 Cardiovalve Ltd. Temperature-control during crimping of an implant
US11504231B2 (en) 2018-05-23 2022-11-22 Corcym S.R.L. Cardiac valve prosthesis
US11672657B2 (en) 2018-10-05 2023-06-13 Shifamed Holdings, Llc Prosthetic cardiac valve devices, systems, and methods
US11471282B2 (en) 2019-03-19 2022-10-18 Shifamed Holdings, Llc Prosthetic cardiac valve devices, systems, and methods
US11707355B2 (en) 2020-05-28 2023-07-25 Medtronic, Inc. Modular heart valve prosthesis
US11464634B2 (en) 2020-12-16 2022-10-11 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation with secondary anchors
US11759321B2 (en) 2021-06-25 2023-09-19 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
US11925553B2 (en) 2021-11-08 2024-03-12 Mitral Valve Technologies Sarl Valve docking devices, systems and methods
US11918461B2 (en) 2023-05-15 2024-03-05 Edwards Lifesciences Corporation Methods for treating a deficient native mitral valve

Also Published As

Publication number Publication date
EP2429455B1 (en) 2021-11-10
WO2010127041A4 (en) 2011-02-17
US20210161657A1 (en) 2021-06-03
NZ596179A (en) 2014-05-30
EP2429455B8 (en) 2021-12-15
AU2010241596A1 (en) 2011-11-24
CA2760461A1 (en) 2010-11-04
EP2429455A1 (en) 2012-03-21
CA2760461C (en) 2014-10-07
WO2010127041A1 (en) 2010-11-04
US20220110748A1 (en) 2022-04-14
EP4035623A1 (en) 2022-08-03
NZ624106A (en) 2015-12-24
AU2010241596B2 (en) 2013-10-24

Similar Documents

Publication Publication Date Title
US20210161657A1 (en) Apparatus and method for replacing a diseased cardiac valve
US20230277315A1 (en) Method for implanting a cardiovascular valve
US10939999B2 (en) Apparatus and method for replacing a diseased cardiac valve
US7611534B2 (en) Percutaneous atrioventricular valve and method of use
CN109310500B (en) Heart valve repair device and method of implanting the same
US9326852B2 (en) Method for implanting prosthetic valve
US9579199B2 (en) Method for treating a mitral valve
US8408214B2 (en) Method for implanting prosthetic valve
AU2019253795A1 (en) Device and system for transcatheter mitral valve replacement
AU2014280916B2 (en) Apparatus and method for replacing a diseased cardiac valve

Legal Events

Date Code Title Description
AS Assignment

Owner name: THE CLEVELAND CLINIC FOUNDATION, OHIO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NAVIA, JOSE L.;CHEN, JI-FENG;ZHOU, QUN;SIGNING DATES FROM 20100624 TO 20100707;REEL/FRAME:024873/0871

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION